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Inflammatory Osteolysis 
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The immune response is an essential defense mechanism that protects the human body 
from foreign infection.  Nevertheless, excessive immune response results in high levels of 
inflammation leading to destruction of healthy tissues. In orthopaedic fields, this duality of the 
immune response has been a challenge to the success of arthroplasties. Wear particle-induced 
inflammatory osteolysis is considered a major culprit of implant failure.  Resident osteogenic 
bone cells, such as osteoprogenitors and osteoblasts, are exposed to wear particles. Although 
osteogenic cells are responsible for the initial osseointegration of implants and ongoing bone 
regeneration, their response to wear particles has been underestimated. Thus, the goal of this 
dissertation is to explore the immune mechanisms of osteogenic cells and to identify the role of 
osteogenic cells in particle mediated osteolysis.  
To meet this end, we evaluated the immune capacity of osteogenic cells by exploring 
their ability to phagocytose wear particles and subsequently express pro-inflammatory cytokines. 
We developed a customized JAVA program and confocal microscopy methodology to quantify 
the phagocytic activity of osteogenic cells. Osteoprogenitors and osteoblasts were able to 
phagocytose Titanium (Ti) particles with aggressive actin remodeling. The actin remodeling to 
engulf particles activated ERK-CEBP/b pathway leading to Cox2 and IL6 gene expression. 
 
 
Interestingly, equibiaxial strain also increased inflammatory gene expression such as MCSF, IL6, 
and Cox2 through the ERK pathway. Physiological and super-physiological levels of strain were 
applied to osteogenic cells and macrophage-like cells via Flexcell system. Super-physiological 
strain exaggerated Ti particle induced inflammatory gene expression from osteogenic cells, while 
macrophage-like cells were not affected by strain. Taken together, these data suggest actin and 
ERK-CEBP/b signaling mediates phagocytosis-induced innate immune responses of osteogenic 
cells.  
Next, we confirmed the role of osteogenic cells in inflammatory osteolysis. Although we 
observed that osteogenic cells secrete inflammatory cytokines after phagocytosis of wear 
particles, it was difficult to discern whether osteogenic cells have a major role in inflammatory 
osteolysis because there are a multitude of cells exposed to wear particles at the site of bone 
implant. Thus, we developed an osteogenic cell line specific ERK-dysfunctional mouse using an 
osterix-promoter-driven CRE-loxp system (CRE/dn-MEK1). An in vivo mouse calvaria model 
was utilized to induce inflammatory osteolysis. Ti particles were implanted on top of 
pericranium layer without invasive incision. This approach allowed observation of osteogenic 
cell responses to Ti particles in the pericranium. With this model, we observed severe calvarial 
osteolysis with increased osteoclastogenesis and pro-inflammatory cytokine release of IL6, 
PGE2 and MCSF. Significantly decreased inflammatory cytokine release and macrophage 
migration were observed in the CRE/dn-MEK1 mouse in in vivo mouse calvaria model and in 
vitro experiments. Similar trends were detected in mouse calvaria treated with AZD6244, a 
potent ATP-uncompetitive inhibitor of MAPK/ERK kinase. 
In summary, this study supports hypothesis that (1) osteogenic cells are able to initiate 
inflammatory responses through well established innate immune function and (2) the ERK 
 
 
pathway could be a clinically important therapeutic target for preventing inflammatory 
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List of Figures 
Figure 2.1 Super-physiologic strain synergistically induces inflammatory gene expression 
with wear particles in MC3T3-E1 Cells . (A,B & C) Relative gene expressions of Cox2, 
MCSF, and IL6 in MC3T3-E1 cells are assessed. No treatment (N), Titanium (Ti), physiologic 
strain (PS), super-physiologic strain (SPS), Titanium + physiologic strain (Ti+PS), and Titanium 
+super- physiologic strain (Ti+SPS) groups were compared. All gene expression assay (n = 6 per 
group) is normalized by GAPDH. Each symbol denotes significant differences (P<0.05). (D) 
Immunoblot of MC3T3-E1 cells show the level of phosphorylation of ERK1/2 (phospho-p44, 
phosphor-p42) after  Ti particles stimulation with/without mechanical strain (30000 µƐ).   
 
Figure 2.2 Mechanical strain does not induce significant changes of inflammatory 
responses from Raw264.7 Cells. Relative gene expressions of Cox2, IL6, TNFα and IL1β are 
assessed in Raw264.7 (A,B,C, & D). No treatment (N), Titanium (Ti), super-physiologic strain 
(SPS), and Titanium + super- physiologic strain (Ti+SPS) groups were compared. All gene 
expression assay (n = 6 per group) is normalized by GAPDH. Each symbol denotes significant 
differences (P<0.05) (E) Immunoblot of Raw264.7 cells demonstrates the level of 
phosphorylation of ERK1/2 (phospho-p44, phosphor-p42) after Ti particles stimulation 
with/without mechanical strain (30000 µƐ).   
Figure 3. Inflammatory Responses of Primary Calvaria Osteoblasts and BMMs to Ti 
particle, Super-Physiological Strain and Combination of Both (A&C) Immunoblot of 
primary calvarial osteoblasts and Bone marrow-derived macrophages show the level of ERK1/2 





mechanical strain (30000 µƐ). n = 3 per group. Each symbol denotes significant differences 
(P<0.05).  (B&D) Relative gene expressions of Cox2, IL6, MCSF, TNFα and IL1β are assessed 
in primary calvarial osteoblast and bone marrow-derived macrophages. No treatment (N), 
Titanium (Ti), super-physiologic strain (SPS), and Titanium + super- physiologic strain 
(Ti+SPS) groups were compared. All gene expression assay (n = 6 per group) is normalized by 
GAPDH. Each symbol denotes significant differences (P<0.05) 
Figure 2.4 Actin remodeling in MC3T3-E1 cells after Ti particles treatment with/without 
mechanical strain. (A) Actin dynamics including actin ring (O) and cup (U) formations are 
indentified through actin structure in axial, coronal, sagittal planes, and bright field. (B) The 
orientation of actin filaments in MC3T3 cells were compared in the no treatment, Ti, SPS, and 
Ti+SPS groups.  . Actin filaments of selected area (yellow square box) were magnified and 
projected into X-Y, X-Z and Y-Z planes to visualize actin remodeling. While No Treatment 
group shows actin fibers in alignment, active actin ring (white circle) and cup formations (white 
cup) are detected from Ti treated group. In the presence of SPS, MC3T3-E1 cells still maintain 
their actin fiber in alignment and active actin ring & cup formations. Scale bar in non-magnified 
images is 10µm. Scale bar in magnified images is 1µm. 
 
Figure 2.5 Actin remodeling in Raw264.7cells after Ti particles treatment with/without 
mechanical strain. (A) Actin stress fibers are less organized in Raw264.7 cells, compared to 
MC3T3-E1 cells. Aggressive actin remodeling such as active actin ring (white circle) and cup 
formations (white cup) are detected from Ti treated group. SPS does not affect actin structure 
and remodeling for phagocytosis of wear particles. (B) The quantification analysis of cell 





actin rings shows no significant difference between the Ti group and the Ti +SPS treated group 
in both MC3T3-E1 and Raw264.7 cells. Each group has n=100. 
 
Figure 2.6 Wear particles and strain cause different levels of cell membrane damage in 
MC3T3-31 and Raw 264.7 cells.(A) Membrane damages of no treatment (N), Ti, SPS and 
Ti+SPS groups were assessed with sytox green assay. MC3T3-E1 cells demonstrate 
synergistically increased membrane damaged cell number in Ti+SPS group. Raw264.7 cells, 
however, show similar number of cell membrane damaged cells in Ti+SPS group, compared to 
Ti only treated group. (B) For both MC3T3-E1 and Raw264.7 cells, MTT assay shows similar 
level of metabolic activities in Ti only treated and Ti+SPS treated groups. Each symbol denotes 
significant differences (P<0.05) and each group d had sample size of 5. 
 
Figure 2.7 The ERK pathway regulates inflammatory responses of MC3T3-E1 cells to wear 
particles and mechanical strain. (A) Selective inhibition of pERK1/2 by AZD in MC3T3-E1 
cells is assessed through immunoblot. AZD treatment blocks phosphorylation of ERK induced 
by Ti and mechanical strain.  (B, C & D) After AZD pretreatment, relative gene expressions of 
Cox2, MCSF and IL6 in MC3T3-E1 cells are assessed. No treatment, Ti, Ti+AZD, PS+AZD, 
PS+Ti+AZD, SPS+AZD, and SPS+Ti+AZD groups were assessed. All gene expression assay 







Figure 2.8 The role of ERK pathway as an inflammatory cascade in Raw264.7 cells. (A) 
Selective inhibition of pERK1/2 by AZD in Raw274.7 cells is assessed through immunoblot. (B, 
C & D) After AZD pretreatment, the relative gene expressions of Cox2, IL6, TNFα and IL1β are 
assessed in Raw264.7 cells with  no treatment, Ti, Ti+AZD, PS+AZD, PS+Ti+AZD, SPS+AZD, 
or SPS+Ti+AZD treatments.  All gene expression assay (with n=6 per group) is normalized by 
GAPDH. Each symbol denotes significant differences (P<0.05). 
 
Figure 3.1 In vivo time course experiments of Ti particle induced osteolysis.   
Four different groups of mice calvarium were used for histology analyses; Sham, 1 day Ti 
treated, 3 days Ti treated, and 7 days treated groups. Ti particles (black arrow) were implanted 
on pericranium (white arrow). All sections of each group were stained with Tri-chrome(top row, 
A), CD11b (2
nd
 row, B), and TRAP (3
rd
 row, C).  (A) Tri-chrome sections were photographed at 
10X magnification. (B) CD11b positive cells in pericranium were observed at 40X 
magnification. (C) TRAP positive osteoclasts (red arrow) at suture line were detected at 40X and 
(D) quantified at 10X.   
 
Figure 3.2 In vivo inflammatory responses of pericranium to Ti particle.   
To investigate the effects of inflammation on osteoclastogenesis, same four groups were used for 
histology analyses: Sham, 1 day Ti treated, 3 days Ti treated, and 7 days treated groups. All 
sections of each group were stained with (A) pERK, (B) Cox2, and (C) IL6. The expressions of 






Figure 3.3 Attachment of Ti particles on cell surface.  
(A) The schematic of a customized JAVA program for quantification of Titanium (Ti) particle-
occupied area on the cell surface is shown. (B) Percentage of Ti-occupied area out of total cell 
surface is generated based on images from the JAVA program. Different dose of Ti particles 
were treated to MC3T3-E1 cells with/without 10µm of the Cytochalasin D (CYD) pretreatment. 
n=20. (C) Actin fluorescent image analysis of particle-occupied area illustrates that Ti particles 
(Bright View) are accumulated along with actin filaments (Fluorescent image) and 10µm of 
CYD are able to decrease particle attachment on actin filaments.  
 
Figure 3.4 Actin remodeling for phagocytosing of Ti particles in osteoprogenitor cell.  
(A) Actin filaments of selected area (yellow square box) were magnified and projected into X-Y, 
X-Z, and Y-Z planes by confocal microscopy to visualize actin remodeling. No treatment, Ti, 
CYD, and Ti+CYD group were compared. Scale bar in non-magnified images is 10µm. Scale bar 
in magnified images is 1µm. (B) After Ti treatment, vigorous dynamics including actin ring (O) 
and cup (U) formations were detected in axial, coronal, and sagittal planes. Scale bar represents 1 
µm. (C) The quantification analysis of cell associated with Ti particles is shown. Each group has 
n=300 and * denotes P<0.01. 
 
Figure 3.5 Ti particle mediated-actin remodeling activates the ERK pathway to induce 





(A) Relative gene expressions of TNFα and IL1β in MC3T3-E1 cells are assessed. No treatment 
(N), Titanium (Ti), Cytochalasin D (CYD), and Cytochalasin D + Titanium (Both) groups were 
compared. (B) Immunoblot of MC3T3-E1 cells show the level of phosphorylation of ERK1/2 
(phospho-p44, phosphor-p42) after stimulation of Ti particles with/without CYD. (C&D) 
Relative gene expressions of IL6 and Cox2 in MC3T3-E1 and hMSC-derived osteoprogenitor 
cells are assessed. Every gene expression assay is normalized by GAPDH and n=6. Each symbol 
denotes significant differences (P<0.05). 
 
Figure 3.6 ERK cascades is a key inflammatory pathway in osteoprogenitor cells. (A) 
Selective inhibition of pERK1/2 by AZD is assessed through immunoblot. (B) pERK fluorescent 
image analysis illustrates that (pERK) expression can be induced by titanium particle in MC3T3-
E1 and hMSC-derived osteoprogenitor cells.  These pERK expressions are also located in both 
the nucleus and cytoplasm.  AZD treatment blocks phosphorylation of ERK expression in both 
the nucleus and cytoplasm. (C&D) Relative gene expressions of IL6 and Cox2 in MC3T3-E1 
and hMSC-derived osteoprogenitor cells are assessed. No treatment (N), Titanium (Ti), AZD 
(AZD), and AZD + Titanium (Both) groups were compared. Every gene expression assay is 
normalized by GAPDH and n=6. Each symbol (*, #, $) denotes significant differences (P<0.05). 
 
Figure 3.7 The ERK pathway mediates phosphorylation of CCAAT/enhancer-binding 





(A) Immunoblot of the cytoplasm and nucleus shows phosphorylated ERK1/2 (phospho-p44, 
phospho-p42), phosphorylated CEBP-β (phosphor-CEBP-β), GAPDH, and Lamin A/C after Ti 
particle stimulation with/without AZD or CYD in MC3T3-E1 cells. Effective separations of 
nuclei and cytoplasm have been confirmed by GAPDH and Lamin A/C detection. (B&C) 
Prostaglandin E2 (PGE2) and IL6 secretion is measured by ELISA. MC3T3-E1 cells were 
treated with Ti particles for three different time points (3hr, 6hr and 24hr) in the presence or 
absence of AZD and CYD pretreatment. Each symbol (*, #, $) denotes significant differences 
(P<0.05). 
 
Figure 3.8. Model for mechanism of inflammatory responses to Ti particles in progenitor 
cell.   
 
Figure 3.9 Cytochalasin D has no direct effects on the ERK pathway mediated-
inflammatory responses. 
(A) CYD neither decreases nor increases phosphorylation of ERK1/2 which is elevated by 
Lipopolysaccharide (LPS). Total ERK (t-ERK) was examined as a loading control. (B&C) 
Selectivity of CYD is assessed through relative gene expressions of IL6 and Cox2 in MC3T3-E1 
cells. Every gene expression assay is normalized by GAPDH and n=6. Each symbol denotes 
significant differences (P<0.05). 
 
Figure 4.1. CRE/dn-MEK1 mice show decreased metal particle induced osteoclastogeneis 





and CRE/dn-MEK1 transgenic mice. B) H&E images of the coronal calvaria bone with 2X and 
10X magnification. C) Immunohistochemical staining of pERK positive cells after Ti particle 
implantation in WT and CRE/dn-MEK1mice (40X). D) Immunostaining of TRAP positive 
osteoclasts (white arrow) in Ti treated WT and CRE/dn-MEK1 mouse calvaria. E)Quantification 
analysis of TRAP positive osteoblasts under 10X magnification.  
 
Figure 4.2. Inhibition of the ERK pathway in osteogenic cells minimizes Ti-particle-
induced bone resorption. A) Microcomputed tomography (uCT) images of untreated WT, Ti-
treated WT and Ti-treated CRE/dn-MEK1 mice calvaria (Axial view) B) Coronal suture 
morphology of selected area (yellow line). C&D) Immunohistochemisty staining of WT, WT_Ti, 
and ERK_Ti group for MCSF and IL6. 
 
Figure 4.3. Actin remodeling for Phagocytic function of osteogenic cells is not affected by 
ERK blockage. A-B) Inhibition of ERK in osteogenic cells from CRE/dn-MEK1 mice is 
confirmed through fluorescent immunocytostaining and western blot analysis of pERK, ERK, 
GFP and GAPDH. C) After 3 hours of treatment with fluorescent beads that are smaller than a 
micron, fluorescent images of actin filaments are obtained and projected into axial, coronal and 
sagittal view by confocal microscopy to visualize the internalization of the beads. D) The 
percentage of Ti-occupied area out of the total cell surface is calculated based on images from a 
JAVA program.  E) The quantification analysis of cells associated with Ti particles is shown. 






Figure 4.4. The ERK pathway mediates inflammatory responses of osteogenic cells to metal 
particles through ERK-CEBP/beta signaling cascades. A) Relative osterix and OCN gene 
expression of primary osteogenic cells from WT, CRE/dn-MEK1, and bone marrow 
macrophages (BMM) are assessed to confirm the purity of isolated osteogenic cells from mouse 
calvaria. C) Immunoblots of osteogenic cells from WT and CRE/dn-MEK1 show the level of 
phosphorylation of ERK 1/2 and CEBP/b after stimulation with Ti particles and LPS.  D-G) 
Relative gene expressions of MCP1, MCSF, IL6 and Cox2 in CRE/dn-MEK1 cells are assessed 
to compare with WT cells. Every gene expression assay is normalized by GAPDH and n=6. Each 
symbol denotes significant differences (P<0.05).  
 
Figure 4.5. Osteogenic cells orchestrate inflammatory responses in the macrophages in an 
ERK dependent manner. A-C) Inflammatory gene expression of BMMs after co-cultured with 
Ti-treated osteogenic cells for 24hours. D-F) Osteoclastogenic gene expression of BMMs after 
being co-cultured with Ti-treated osteogenic cells for 5 days.    
 
Figure 4.6. BMMs migration to the site of metal particle implant is accelerated by 
osteogenic cells.  A) Migration of BMMs is assessed through a modified Boyden chamber 
system. BMMs are co-cultured with Ti-treated osteogenic cells without direct contact. Migrated 
BMMs are quantified by measuring relative fluorescence. B) MCP1 expression and CD11b 
positive cell migration In vivo  are observed from Sham, Day 1_Ti, Day 3_Ti, and Day 7_Ti 






Figure 4.7 The effects of AZD treatment on inflammatory responses to Ti particles in vivo.   
Four groups were examined to investigate the effects of AZD on inflammation: Sham, 7 day Ti 
treated, 7 days AZD treated, and 7 days AZD+Ti treated groups. Immunohistochemical staining 
of pericranium was performed with (A) pERK, (B) Cox2 (C) IL6 and (D) CD11b. Magnification, 
40X.  
Figure 4.8. AZD treatment reduces osteoclastogenesis induced by Ti particles in vivo.  
To investigate the effects of AZD treatment on osteoclastogenesis, quantification of TRAP 
positive osteoclasts at the suture line was performed at 10X magnification. Representative TRAP 
positive osteoclasts were photographed from four groups: Sham, 7 day Ti treated, 7 days AZD 
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Chapter 1. Overview 
 
1.1 General Background 
 
1.1.1 Inflammatory Osteolysis 
Inflammation is an essential biological response of tissues to get rid of harmful materials 
such as foreign materials, pathogens, and endotoxin. At the site of injury, immune cells 
recognize infection and initiate inflammatory cascades. The initiated inflammation 
simultaneously causes destruction of the infection and regeneration of damaged tissues.(1-3) 
Without inflammation, wounds and infections would not heal. However, excessive and chronical 
inflammation results in extreme tissue destruction leading to various inflammatory illnesses. In 
the orthopaedic field, the duality in inflammation has been an issue for decades.  
Arthroplasties are effective, reconstructive orthopaedic surgeries for late stage of defective 
hip, knee, shoulder, and finger joint. They are reconstructive procedures to restore the integrity 
and function of joint.  Between 1998 and 2008, total of 4,438,213 total knee arthroplasties and 
2,182,121 total hip arthroplasties procedures were performed in the U.S.(4) Depending on 
patient’s condition, joint can be recovered by resurfacing the bones or be replaced by artificial 
prostheses. Advances in biomaterials have led to an increased usage of orthopaedic and dental 
implants in clinical settings. However, the long term outcome of arthroplasties is limited by 
inflammatory osteolysis and implant instability. Clinical studies have shown that wear debris and 
endotoxin mediated inflammation leads to operative site pain, limitation of motion, and 





Wear particles are constantly generated from the bearing surfaces and surfaces of the 
prostheses. Since various materials such as Titanium (Ti), Cobalt-chromium (Co-Cr) alloy, and 
polyethylene are used for bone implants, different types and sizes of wear particles are 
generated.(8-11)  The presence of metal particles was confirmed by many groups through SEM, 
histological, and optical microscopic analyses. Polyethylene particles from failed shoulder 
implants are globular shape with 0.1-2um diameter range.(12)   Ti alloy particles and Co-Cr 
particles from hip implants are submicron size, and tend to form micron-size clusters.(13, 14) 
The responses of tissues to wear particles are different based on size, composition and 
morphology of the particles. Several studies also have shown that osteolysis is correlated with 
higher wear rates.(15, 16)  The interfacial membrane between bone and implant contains a vast 
volume of wear particles which are associated with perioprosthetic osteolysis.(17)  
Bone tissue is exposed to many different types of mechanical loading, such as strain, 
compression, and shear stress, from daily activities.(18, 19) In response to such mechanical 
perturbations, bone tissue undergoes remodeling through a feedback mechanism.(20) The role of 
mechanical perturbation in subsequent implant loosening has been implicated also in clinical 
studies. Several clinical studies indicated the micro-motion promoted implant loosening by 
preventing osseous ingrowth into the implant.(21-24) As many bone cells can sense mechanical 
forces on bone and consequently induce cellular signaling, it is important to study the effects of 
the mechanical perturbation on bone turnover. Although bone cells at the implant junction are 
exposed to wear particles and mechanical loading at the same time simultaneously (25, 26), the 
effect of simultaneous exposure to these factors has not been extensively studied. 
 Due to the clinical significance, inflammation at the host bone-implant interface has 





wear particles can cause foreign body reaction and subsequent bone resorption (7). 
Immunohistochemical (IHC) and mRNA studies on the human tissues from patients, who 
received revision surgeries, confirmed the high expression of TNF-α, IL-1, IL-6, PGE-2 and 
RANKL (27). Therefore, it is important to understand the mechanism of the inflammatory 
cascades at the bone-implant interface to minimize and prevent aggravation of osteolysis.  
1.1.2  Bone cells 
Bones are dynamic organs that not only provide structural support but also influence 
metabolism by regulating calcium releases.(28) Bones undergo constant remodeling  to regulate 
bone mass and volume homeostatically. Three major classes of bone cells are involved in the 
bone homeostasis: osteoblasts, osteoclasts, and osteocytes. Osteoblasts, known as a bone forming 
cells, synthesize bone matrix components and collagen.(28)  Osteoblasts are differentiated from 
osteoprogenitor cells which are found in large number at the periosteum layer.(29-31)  For 
osteoblastic differentiation, osterix and cbfa1/Runx2 are key transcription factors.(32-34) When 
osteoblasts induce enzymes to calcify bone matrix, some of them are buried under bone 
mineralized matrix and are differentiated into osteocytes. Osteocytes have recently attracted 
particular interest as an important regulator of osteoblast and osteoclast differentiation. More 
than 90% of bone cell populations are osteocytes which have important functions in bone 
remodeling. Recent studies have shown that osteocytes induce cellular signaling through 
canaliculi by sensing mechanical force and fluid flow in bones.(35-37) Osteoclasts are 
multinuclear giant cells which resorb bone tissue by secreting acid and collagenases. Osteoclasts 
release calcium ion from bones into blood fluid. (38) Osteoclast precursors such as monocytes 





 The activities of osteoblast-like and macrophage-like cells are closely coupled. Recent 
studies have shown that secretion of the receptor activator of nuclear factor-kB ligand (RANKL) 
and macrophage colony-stimulating factor (MCSF) from osteoblastic cells and osteocytes induce 
macrophage fusion leading to osteoclastogenesis.(28, 39, 42, 43) Osteoprotegerin (OPG), which 
is also expressed by osteoblast like cell linage, is a decoy receptor for RANKL. OPG binds to 
RANKL and decreases osteoclastogenesis by nuclear kappa B (NF-kb) intracellular 
signaling.(44, 45) Imbalance between osteoclasts and osteoblastic cells’ activities induces 
impaired bone turnover such as osteoporosis and osteopetrosis. Since the three major cell 
lineages orchestrate bone homeostasis, the cellular communication between those cells is an area 
of recent focus.   
1.1.3 Innate Immune Function 
The immune system comprises the innate immune system and adaptive immune system. 
The innate immune system defends the host from infections in a non-specific manner while the 
adaptive immune system is highly specific and systemic process.(46, 47) As the first line of 
defense, innate immune cells, such as macrophages, dendritic, and natural killer cells, are known 
to identify pathogens and to initiate inflammation. At the site of infection, innate immune cells 
recruit more immune cells by secreting chemokines and activating the adaptive immune 
system.(48, 49) 
Innate immune cells share common precursors such as monocytes and macrophages with 
bone cells.(28) In addition to their immune function, matured macrophages and monocytes are 
able to differentiate into osteoclasts.(50) In the orthopaedic setting, the function of these immune 
cells causes unnecessary inflammation at the host bone-implant interface leading to severe 





inflammatory mediators in the orthopaedic field. Macrophages and monocytes accumulate at the 
host-implant interface and engulf wear particles.(51) The wear particle contacted macrophages 
initiate actin-driven phagocytosis leading to the secreting of several inflammatory cytokines such 
as IL1β and TNFα, which significantly affect cellular behavior.(3, 27, 52, 53) The excessive 
inflammatory cytokines secretion enhances osteoclastogenesis and decreases osteoblast 
activities. Consequently, an imbalance between bone formation and resorption results in bone 
resorption and implant failure. Unlike macrophages, the role of osteoblast like-cells in host 
defense is not well studied. Since activities of macrophages and osteoblast-like cells are closely 
linked, it is necessary to study the inflammatory responses of osteoblast-like cells and their 
interaction with osteoclast precursors.    
1.1.4 Phagocytosis  
For cellular nutrition, eukaryotic cells undergo an extracellular nutritive molecular 
internalization process, called endocytosis.(54) As a form of endocytosis, phagocytosis is the 
process of cells to engulf solid particles larger than 0.75um in diameter.(55) In addition to 
nutrition acquisition, the phagocytosis process involves in immune system and host defense by 
engulfing and digesting pathogens.(56) Phagocytosis is known as a receptor mediated process. 
As many different types of particles are known to be phagocytized, it is not surprising that many 
different types of phagocytosis related receptors present on the cellular surface.  Monocytes, 
macrophages and neutrophils are known as professional phagocytes which have efficient 
phagocytic receptors including Fcγ receptor and complement receptor 3. These receptors are 
activated upon particle binding and induce a zipper-engulfment mechanism through actin 
remodeling, leading to formation of phagosomes.(52, 57, 58) As downstreams of phagocytic 





filaments leading to internalization. The internalized phagosomes fuse with lysosome and form 
phagolysosomes. The phagolysosomes are acidified vesicles which destroy pathogens inside. 
The phagocytosis process induces various intracellular signals and affects cellular behaviors. 
Several groups have shown that particle containing macrophages release inflammatory 
cytokines, regulate cell differentiation and promote programmed cell death.(56, 59)  CDC42 is 
identified as a pivotal regulator of Fcγ receptor mediated phagocytosis.(60) Although many 
studies are performed regarding pathogen activated phagocytic receptors, surprisingly little is 
known about how metal particles are recognized by immune cells and interact with the cell 
surface.   
 
1.1.5 Inflammatory Signaling Pathway  
The culprit behind aseptic implant loosening is believed to be wear particles such as titanium 
(Ti), polyethylene, and cobalt chromium. These particles are phagocytized and initiate pro-
inflammatory intracellular signaling from various cell types.(2, 3, 25, 53) As we described 
earlier, it is still unclear which receptors are responsible for these wear particles. There is a study 
that indicates polyethylene particles are opsonized and activate complex receptors.(61) By 
contrast, opsonization is not required for macrophages to engulf Ti particles.(62-64) Inhibition of 
the scavenger receptor, MARCO, results in decreased Ti particle phagocytosis from 
macrophages, however, PMMA and Co-Cr particles are not affected by MARCO.(62) Varying 
results from many different studies suggest different surface receptors are responsible for 
different types of particles depending on composition, size, shape and volume.  
Engulfment of wear particles induces inflammatory intracellular signaling. MAP kinases 





processes such as cell differentiation and apoptosis. In particular, ERK, a serine/threonine-
specific end effector of the MAPK pathway, regulates transcription factors that are involved in 
cell proliferation and survival.(65) In the context of inflammatory osteolysis, Ti, Co-Cr, and 
polyethylene particles activate three major MAPK subgroups (p38, ERK and JNK). The 
stimulated MAPK signaling leads to activation of inflammatory transcriptional factors 
expression of pro-inflammatory cytokines, further augmenting the expression of pro 
inflammatory cytokines.(66) As many studies have shown, Nuclear factor kappa of B cells (NF-
kB), AP-1, and NF-IL6 are identified as key inflammatory transcriptional factors that are 
activated by wear particles.(67, 68) However, the associations of these factors are still not well 
studied.    
 
1.1.6 Motivation  
Recently many studies extensively scrutinized pro-inflammatory cytokines induction 
from various cell lines to identify inflammatory cascades.  Although bone tissues at the implant 
surfaces are exposed to various stimuli such as wear particles and altering mechanical loading 
simultaneously, recent studies have been focused on individual stimulus. Also, these intense 
studies are focused on mainly macrophages and monocytes. Since osteogenic cell lines derived 
from mesenchymal stem cells are responsible for both initial osseointegration of implants and 
ongoing bone regeneration, it is important to elucidate the responses of osteoblast-like resident 
cells to wear particles and their effects on other cells. There is a knowledge gap in the signal 
transduction mechanism by which mechanical perturbation and wear particles co-promote 
periprosthetic inflammatory bone loss at the molecular level.  We propose to delineate the role of 





vivo models. The results of our proposed experiments are expected to show a strong influence on 
clinical/therapeutic bone biology by (1) Identifying the role of osteoblast-like cells in 
inflammatory osteolysis (2) Defining the ERK pathway as a key inflammatory pathway (3) 
Establishing a potential therapeutic effect of anti-‘ERK Pathway’ on inflammation-related 
bone loss. Successful completion of the study will add novel scientific knowledge and new 
therapeutic answers to various inflammatory musculoskeletal disorders thereby driving the 
research field forward and enhancing musculoskeletal health. 
 
1.2 Specific Aims & Impact 
1.2.1  Specific Aims  
 To guide our effort, the following specific aims and hypotheses are proposed: 
Specific Aim 1: To Determine Whether Osteogenic Lineage Mediates Inflammatory Bone Loss 
by Regulating Inflammatory Cytokines 
Hypothesis & Rationale: Osteogenic cell lineage mediates osteolysis through inflammatory 
cytokine release. The primary function of osteoblast-like cells is to form bone tissue that 
constitutes the skeletal system. Recent studies have highlighted additional roles of 
osteoprogenitors and osteoblasts in the regulation of osteoclastogenesis by elaborating the 
function of RANKL, MCSF and inflammatory gene expression. Since osteoprogenitors are 
resident cells at the host bone-implant interface, fundamental questions arise as to the role of 
osteoprogenitor cells at the host bone-implant interface and their ability to initiate a cascade of 
inflammatory responses. Although many studies have examined the interaction between 
biomaterial debris and macrophages, the role of osteoprogenitor cells in biomaterials-related 






Specific Aim 2: To determine the role of ERK pathway in inflammatory osteolysis 
Rationale and Hypothesis: Our preliminary data has shown that ERK regulates the expression of 
IL6, Cox2 and M-CSF which are critical molecules for inflammatory bone loss. Specific Aim 2 
focuses on in-detail investigation of inflammatory mechanisms for better understanding of 
osteoblast like cell mediated osteolysis. Based on our preliminary data, we speculate that the 
osteoblast like cells might have unrecognized innate immune receptors associated with actin-
mediated phagocytosis and inflammatory intracellular signaling. First, we will elucidate 
phagocytic capacity of osteogenic cells by analyzing actin remodeling. Then we will define 
whether the phagocytosis-induced actin remodeling triggers inflammatory signals and ERK 
phosporylation from Ti particles. Third, we will determine the role of ERK pathway through 
osterix driven ERKdef mice in vivo & in vitro. We hypothesize that ERKdef mice show inhibited 
pERK expression and less inflammatory osteolysis   
1.2.2   Organization  
This thesis consists of three major studies: (1) Aggravation of Inflammatory Response by 
Costimulation with Titanium Particles and Mechanical Perturbations in Osteoblast- and 
Macrophage-like Cells (2) Actin and ERK1/2-CEBPβ signaling mediates the phagocytosis-
induced innate immune response of osteoprogenitor cells (3) Innate Immune function of 
Osteogenic lineage and its therapeutic potential in Inflammatory osteolysis 
In Chapter 2, the intracellular mechanism of osteoprogenitor cells and macrophages cells 
in the inflammatory cascade was investigated through MC3T3-E1 and Raw264.7 cells.  The key 





further examined the effects of equibiaxial strain on phagocytic capacity and cellular damage 
through customized immunostaining analysis.  
We utilized the mouse calvaria resorption model to study the role of osteoprogenitor cells 
in metal particle-mediated osteolysis for Chapter 3.  In this model, Ti particles were implanted 
on the mouse pericranium, inducing an inflammatory response with osteolysis, which closely 
mimic the inflammatory response observed in clinical aseptic loosening. The mouse calvarial 
bone loss model is ideal for our proposed study since we can examine the expression of IL6, 
Cox2 and M-CSF in the sutural cells of osteoblastic lineage without interference of other bone 
marrow resident cells. In addition, osteoclasts are virtually absent in the sagittal suture region so 
we can easily identify osteoclasts which are formed in response to biomaterials.   Outcomes were 
evaluated by immunohistochemical analyses.  Next, the intracellular mechanism of 
osteoprogenitor cells in the inflammatory cascade was further investigated.  We elucidated the 
phagocytic capacity of osteoprogenitor cells by analyzing actin remodeling and investigated a 
key intracellular signal transduction process through Real time RT-PCR, ELISA, Western blot, 
and Immunostaining.   
In Chapter 4, we employed osteogenic lineage-specific dominant negative MEK1 mice 
(ERKdef). We examined and compared outcomes such as the expression of Cox2, IL6 and 
MCSF expression by immunohistochemistry, count the number of TRAP-positive multinucleated 
cells, and measure the area of the sagittal suture in wild-type and osteoblast specific ERKdef 
mice calvaria treated with Ti wear particles. Precise calvaria bone volume after Ti-induced 
osteolysis was measured and bone architecture was reconstructed using micro CT (uCT). Effects 
of osteogenic lineage induced inflammation on macrophages were examined through co-culture 





measured after co-culturing using a trans-well system.  Migration ability and protein expression 
of both cell lines were also tested. To examine whether ERK inhibition is clinically useful and 
feasible for reducing osteoclastogenesis and inflammatory-osteolysis, we tested our hypothesis in 
a rodent calvaria which allows inflammatory cytokine and TRAP positive osteoclast histology 
analysis. The study examined whether AZD6244 diminishes wear particle-induced osteolysis.  
















Chapter 2. Aggravation of Inflammatory Response by 
Costimulation with Titanium Particles and Mechanical 
Perturbations in Osteoblast- and Macrophage-like Cells  
2.1 Introduction  
Joint arthroplasty is an effective treatment for end stage osteoarthritis.   However, the 
long term outcome of joint arthroplasties is limited by implant instability and inflammatory 
osteolysis.(5, 7, 69) As shown in numerous clinical studies, bone implants generate a large 
quantity of wear debris, which alters the mechanical environments at the bone-implant interface 
and initiates inflammatory osteolysis potentially through phagocytosis.(70-73)  
Wear particle induced inflammatory osteolysis is influenced by macrophages and 
osteoprogenitor cells.  Macrophages are one of the main phagocytic cells which engulf wear 
debris and secrete inflammatory cytokines such as IL1β, TNFα, and IL6.(53, 57, 74, 75) These 
secreted cytokines significantly affect cellular behaviors, leading to osteoclastogenesis.  
Additionally, osteoprogenitor cells also regulate osteoclastogenesis by secreting RANKL, OPG, 
and MCSF.(42, 76) In our previous studies, we noted the innate immune function of 
osteoprogenitor cells and revealed the potential synergistic effects between these cells and 
macrophages in inflammatory osteolysis.(66)  
Bone tissues are exposed to many different types of mechanical loading, such as strain, 
compression, and shear stress, from daily activities. In response to these mechanical loading, 
bone cells continually remodel bone structures through a feedback system. The altered 





potentially leading to implant failure.  Even though bone cells at the implant surfaces are 
exposed to wear particles and altering mechanical environments simultaneously, the effects of 
mechanical perturbation on cells exposed to wear debris have not been extensively studied.  In 
this study, the responses of macrophages and osteoprogenitor cells to mechanical perturbation 
and wear debris were studied to elucidate the role of these cells on bone remodeling and osseous 
integration regulation.  
The objectives of this study were to investigate the effects of mechanical strain, wear 
particles, and the combination of both on [1] the inflammatory responses of macrophages and 
osteoprogenitor cells, and [2] the intracellular mechanism in the inflammatory cascade.  To 
achieve our objectives, the cyclic equibiaxial strain and titanium (Ti) particles were utilized for 
this study.   
 
2.2 Materials and Methods  
2.2.1 Study design 
The intracellular mechanism of osteoprogenitor cells and macrophages in the 
inflammatory cascade was investigated in MC3T3-E1 and RAW 264.7 cells, primary calvarial 
osteoblasts, and bone marrow-derived macrophages (BMMs). The key inflammatory signaling 
pathway was investigated using real-time RT-PCR and Western blotting. We used customized 
immunostaining analysis to examine the effects of equibiaxial strain on phagocytic capacity and 
cell damage. 





 Cells from the murine preosteoblastic cell line MC3T3-E1 were purchased from 
American Type Culture Collection (Manassas, VA) and maintained in MEMα (Invitrogen) 
supplemented with 10% FBS (Gemini Bio-Products, Woodland, CA) and 1% 
antibiotic/antimycotic (Gemini BIO-Products) at 37°C and 5% CO2. Murine macrophage-like 
RAW 264.7 cells were purchased from American Type Culture Collection and maintained in 
DMEM (American Type Culture Collection) supplemented with 10% FBS (Gemini Bio-
Products) and 1% antibiotic/antimycotic (Gemini Bio-Products). 
Six-week-old male C57BL/6J mice were purchased from Jackson Laboratory for primary 
osteoblast and BMM isolation. Primary osteoblasts were isolated from calvaria of 6-wk-old 
C57BL/6J mice by enzymatic digestion (77). After removal of the suture, calvaria were chopped 
into small (~1–2 mm2) fragments. Bone pieces were incubated in collagenase II-trypsin solution 
for 2 h. The bone pieces were washed with PBS and placed in 10-cm cell culture plates with 
DMEM supplemented with 10% FBS (GIBCO, Grand Island, NY), antibiotics (1.25 g/ml 
amphotericin B, 100 U/ml penicillin G, and 100 μg/ml streptomycin), 10 mM β-
glycerophosphate (Sigma), and 100 μg/ml L-ascorbic acid (Sigma). The culture plates were kept 
at 37°C and 5% CO2. Cells are incubated with differentiation medium for 14 days. Differentiated 
primary calvarial osteoblasts expressed a high level of alkaline phosphatase (77). 
BMMs were harvested from long bone of C57BL/6J mice, as described elsewhere (78). 
Briefly, the nonadherent fraction of mouse bone marrow cells was cultured in a 10-cm culture 
dish with MEMα (Invitrogen) supplemented with 10% FBS (Gemini Bio-Products), 1% 
antibiotic/antimycotic (Gemini Bio-Products), and 10 ng/ml recombinant mouse M-CSF (R & 
D). The resulting adherent purified BMMs were collected and subsequently cultured in serum-





AZD6244 (ARRY-142886, AZD), a potent, selective, and ATP-uncompetitive inhibitor of 
MAPK/ERK kinase-1/2, was purchased from Selleck Chemicals (Houston, TX). AZD was used 
to treat cells for 1 h prior to the particle treatment, which consisted of 3 h of direct stimulation of 
cells with Ti particles. 
All procedures and animals use were approved by the Institutional Animal Care and Use 
Committee. 
 
2.2.3 Titanium Particles  
Commercially available pure titanium particles (Ti) with an average diameter within 0.3-
1μm, were purchased from Johnson Matthey Chemicals (Ward Hill, MA) as previously 
described by Ragab et al (79).  To remove endotoxin from the particles, ten cycles of the 
following two steps were performed.  In the first step, Ti particles were incubated in 25% nitric 
acid at room temperature for 20 hours followed by washing three times with phosphate-buffered 
saline (PBS).  In the second step, the Ti particles were treated in a mixture of 0.1 N NaOH and 
95% ethanol at 30°C for 18-20 hours, followed by five time-washes with PBS between cycles. 
The endotoxin level was determined by Limulus Amebocyte Lysate kit (i.e.<0.01EU/ml).  Prior 
to use, particles were sonicated for 15 minutes to avoid particle aggregation.  Cells were directly 
stimulated with Ti particles for 3 hours. Unattached particles were flushed by rinsing the plates 
10 times with PBS, followed by inverting the plates for 10 minutes to allow any residual 
unattached particles to be removed by gravity. 
 






  Cyclical equibiaxial tensile strain was applied to cells.  The cells were cultured on 6-well 
plates with a silicone elastomer membrane (Flexcell Inc., Hillsborough, NC) for tensile loading.  
Cells were exposed to 5000 microstrain (µƐ) and 30000 microstrain (µƐ) at 1 Hz for various time 
points (FX4000T; Flexcell Inc.).  The 5000µƐ and 30000µƐ of equibiaxial strain were selected to 
represent normal physiologic (PS) and super-physiologic mechanical loading (SPS), 
respectively; these strain levels were previously observed at the periprosthetic interface between 
host bone and the implant (80, 81) . 
  
2.2.5 RNA Isolation and Real-Time RT-PCR 
Immediately after the stimulation, total RNA was isolated from cells using an RNeasy 
Mini Kit (Qiagen).  The 260/280 absorbance ratio was measured for verification of the purity of 
RNA. Single stranded cDNA was synthesized from total RNA with the SuperScript III system 
(Invitrogen). Realtime RT-PCR for each target was performed with LightCycler FastStart DNA 
Master
PLUS
 SYBR Green I (Roche) using the Realplex system (Eppendorf). Primers sets used 
were: for mouse-GAPDH, (5'-AGAACATCATCCCTGCATCC-3') and (5'-
AGTTGCTGTTGAAGTCGC-3'); for mouse-IL6, (5'-AAAGCCAGAGTCCTTCAGAG-3') and 
(5'-CTAGGTTTGCCGAGTAGATC-3'); for mouse-Cox2, (5'-
ACATCGATGTCATGGAACTG-3') and (5'-GGACACCCCTTCACATTATT-3'); 
for mouse-IL1b (5'-CCTGTGTAATGAAAGACGGC-3'), and (5'-
GGAAGACACAGATTCCATGG-3'); for mouse-TNFa, (5'-GTTCTCTTCAAGGGACAAGG-





AAGAGAAGTACCAGGGATCG-3'), and (5'-TCCAATGTCTGAGGGTTTCG-3'). The 
thermal cycling conditions consisted of preheating (10 min at 95°C), 40 cycles of denaturation 
(15 sec at 95°C), annealing (15 sec at 60°C), and elongation (20 sec at 72°C).  For each sample, 
mRNA levels of each gene were normalized to GAPDH levels. 
 
2.2.6 Protein Isolation & Western Blot Analysis  
The Nuclear Extract Kit (Active Motif, Carlsbad, CA) was used to isolate nuclear and 
cytoplasmic extracts. These extracts were further homogenized by sonication for 15 strokes at a 
10% duty cycle and 4 °C (Sonifier 250; Branson, Danbury, CT). The samples were centrifuged 
at 10,000×g for 10 minutes, and the supernatant was collected for analysis. Protein quantification 
was performed using the BCA Protein Assay (Pierce, Rockford, IL) reagents, and 20 μg of 
protein extract underwent Western blotting. Samples were run in 4–20% SDS-polyacrylamide 
gels (Invitrogen) and electrotransferred to PVDF membranes, which were blocked and probed 
with primary antibodies overnight at 4 °C. Excess antibodies were washed off from the blots 
with Tris-buffered saline containing 0.1% Tween 20 (TBS-T) and with 10% FBS.  Blots were 
furtherprobed with a HRP-conjugated secondary antibody (Cell Signaling Technologies, 
Beverly, MA), and detected using the enhanced chemiluminescence (ECL) reagents (Amersham 
Pharmacia Biotech, Piscataway, NJ).  Membranes were stripped with Restore® Western blot 
stripping buffer (Pierce) and reprobed with GAPDH (Chemicon, Temecula, CA) antibodies as 
loading controls. 
 





  After the Ti treatment and strain stimulation, 3D images of GFP(+) actin stained cells 
were obtained with a confocal microscope (axial slice thickness of 0.22µm, reformatted in X,Y, 
and Z dimensions). To study actin remodeling, actin filaments in a selected area were magnified 
and reformatted into X-Y (Axial), X-Z (Coronal), and Y-Z (Sagittal) planes. 3D imaging allowed 
us to distinguish completely phagocytosed (internalized) particles and partially phagocytosed, 
membrane-bounded particles. While the internalized particles are fully covered by actin 
filaments in all views (Ring pattern: O), partially phagocytosed particles show a hemisphere of 
actin filaments in the sagittal and coronal view (Fig 3, Cup pattern: U). For quantitative analysis 
of phagocytosis, we selected a hundred cells that exhibited Ti attachment and counted the 
number of cells with internalized particles. 
 
2.2.8 Detection of Cell Membrane Damage & Death  
Membrane damage was evaluated by Sytox Green assay. After Ti treatment, 1µm of 
Sytox Green was added to each well of 6 well plate for 1hr with equibiaxial strain .  All cells 
were visualized using the Axiovert imaging system (Zeiss, Thornwood, NY). For quantitative 
analysis, we randomly selected a hundred cells in bright field and counted the number of nucleus 
stained cells under fluorescent microscope. Cell death by wear particles and mechanical 
perturbation was examined through MTT assay (Invitrogen). MTT assay kit was purchased from 
Invitrogen and was utilized according to manufacturer’s instruction. After Ti and strain 
treatments, cells were incubated for 4 hrs at 37°C with 50 µg/mL concentration of MTT. SDS-
HCL solution was added to the wells. After 4 hr incubation, MTT absorbance was read at 






2.2.9 Statistical Analysis 
An one-way ANOVA was used to test for the effects of Ti, mechanical strain, AZD, and 
combination effects on phagocytic activity and inflammatory gene expression.  The significance 
between levels for each of the factors was checked with Student Newman-Kuels multiple 
comparisons tests.  Statistical significance was taken as p < 0.05.  
 
2.3 Results 
2.3.1 Super physiological level of cyclic equibiaxial strain exaggerates wear particle-
mediated inflammatory gene expression in osteoprogenitor cell 
To investigate the effects of equibiaxial strain on wear particle-induced osteolysis, we 
assessed the relative mRNA expression of inflammatory genes, osteoclastogenic genes, and 
phosphorylated ERK expression in osteoprogenitor cells using real time RT-PCR and western 
blot.  The relative mRNA expressions of inflammatory genes, including IL6, Cox2, IL1β, and 
TNFα, were examined.  Ti particle stimulation of MC3T3-E1 cells significantly increased the 
IL6 and Cox2 mRNA levels (Fig.2.1.A,B&C), while TNFα and IL1β mRNA levels were 
unaffected by particle treatments (Data has not shown). Exposure to either physiologic stretch or 
super-physiologic stretch did not statistically change the level of IL6 mRNA expression in 
MC3T3-E1 cells.  However, subsequent exposure to super physiologic stretch after particle 
treatment resulted in a synergistic increase in IL6 mRNA expression (Fig 2.1.C). Similarly, the 
level of Cox2 mRNA expression in MC3T3-E1 cells also reflects similar trends as IL6 mRNA 





osteoclastogenic gene, relative mRNA expression of MCSF was examined.  The level of MCSF 
mRNA expression was significantly increased in the particle and super-physiologic groups (Ti, 
SPS) (Fig. 2.1.B).  Additional increases were also seen in the combined groups of physiologic 
stretch with particles (Ti+PS) and super physiologic stretch with particles (Ti+SPS) (Fig. 2.1.B) 
Correspondingly, the level of phosphorylated ERK was synergistically increased after one hour 
of super physiological level of mechanical strain, subsequent to Ti particle exposure. (Fig. 
2.1.C). 
 
2.3.2 Particle mediated inflammatory gene expression in macrophages are not affected by 
mechanical perturbation 
 Since macrophages play a crucial role in wear particle mediated osteolysis, we examined 
the effects of mechanical perturbation on particle mediated inflammatory gene expression in 
macrophages.  All inflammatory gene expressions such as IL6, Cox2, TNFα, and IL1β increased 
after Ti treatment (Fig. 2.2.A, B, C & D). Unlike the osteoprogenitor cells, the level of these 
inflammatory gene expressions in macrophages was not amplified by super-physiological level 
of equibiaxial stretch. Also, Ti induced inflammatory gene expression was not further increased 
by super-physiological strain. Western blot analysis also has not shown a distinct difference in 
the level of phosphorylated ERK between the Ti only group and the Ti+SPS treated groups (Fig. 
2.2.E). 







Inflammatory responses of primary calvarial osteoblasts and BMMs to Ti particles and 
super-physiological strain were investigated and compared to MC3T3-E1 and Raw264.7 
cells.(Fig. 2.3) Similar to responses of progenitor cells, both primary calvarial osteoblasts and 
BMMs had increased inflammatory gene expressions (IL6, Cox2, M-CSF, IL1b & TNFa) as well 
as pERK expression under Ti treatment. pERK protein expression as well as IL6, Cox2, and M-
CSF gene expression increased with super-physiological strain in primary calvarial osteoblast 
and showed additional heightened gene expression levels in cells treated with combined 
stimulation of Ti particles and super physiological strain. BMMs were less sensitive to super-
physiological strain and exhibited no additional inflammatory responses under combined 
stimulation. 
2.3.4 Effects of mechanical perturbation induced actin remodeling on wear particle 
phagocytosis 
The effect of equibiaxial strain on Ti particle-induced actin remodeling was investigated 
via the analysis of confocal images.  In our prior study, we utilized the novel quantitative method 
of phagocytosis analysis through actin remodeling investigation.(82)   Briefly, the completely 
internalized particles were identified through actin ring formation (O in Fig.2.4A), and 
membrane bounded particles were identified through actin cup formation (U in Fig.2.4A).  Using 
this method, we detected actin cup and ring formation in both MC3T3-E1 and Raw264.7 cells 
when treated with titanium particles (Fig2.4 & 2.5). In the no treatment groups, the actin fibers in 
MC3T3-E1 cells were highly organized and aligned with uniform orientation, while  the actin 
fibers in Raw264.7 cells demonstrated less overall alignment (Fig 2.4 & 2.5).  Cells under super 
physiological level of equibiaxial strain had no clear changes in their actin structure. Subsequent 





filaments with actin cup and ring formation.  Among the cells that exhibited Ti attachment, 
approximately 40% of the cells internalized Ti particles in both Ti only and Ti+SPS group (Fig. 
2.5B). Although it showed less organized baseline actin fibers alignment, the Raw264.7 cells 
also have similar trends of actin stress fiber under Ti and Ti+SPS exposures. Among the cells 
with Ti attachment from both Ti only and Ti+ SPS groups, approximately 80% of the cells 
internalized Ti particles. (Fig.2.5 B&C) 
 
2.3.5 Membrane damages by wear particles and cyclic equibiaxial strain  
 Membrane damages in MC3T3-E1 and Raw264.7 cells were assessed with Sytox Green 
assay.  About 15% of MC3T3-E1 and Raw264.7 cells revealed membrane damages after Ti 
treatment.  About 10% of MC3T3-E1 cells were damaged by super-physiological level of 
equibiaxial strain (SPS), while Raw264.7 cells were not affected.  When both Ti particles and 
super-physiological level of strain were applied to MC3T3-E1 cells (Ti+SPS), the percentage of 
membrane damaged cells was increased up to 40%.  However, no significant changes were 
detected in Raw264.7 cells with both treatments (Ti+SPS) (Fig. 2.6.A). Cell viability analysis 
using MTT assay showed decreased absorbance level in Ti group, compared to no treatment 
group in both MC3T3-E1 and Raw264.7 cells. Unlike sytox green assay, the MTT assay for the 
Ti +SPS group revealed similar level of absorbance as the Ti group.  
 
2.3.6 Wear particle and mechanical perturbation synergistically increase inflammation 






To further elucidate the role of ERK in the inflammatory osteolysis, the effect of wear 
particle treatment and mechanical perturbation on MC3T3-E1 and Raw264.7 cells were 
examined under the presence of AZD6244(AZD).  Cells treated with AZD exhibited a selective 
and drastic inhibition of the ERK phosphorylation, which is induced by Ti particles in both 
MC3T3-E1 and Raw264.7 cells.  The level of pERK expression correlated well with Cox2, 
MCSF, and IL6 expression in MC3T3-E1.  Real time RT-PCR verified that Ti particles elevated 
the IL6, MCSF, Cox2, IL1b, and TNFɑ mRNA, while AZD pretreatment dramatically decreased 
the inflammatory gene expression in both MC3T3-E1 and Raw264.7 cells (Figure 2.7 & 2.8).  In 
both MC3T3-E1 and Raw264.7 cells, no synergistic increase in inflammatory gene expressions 




Osteolysis occurs in clinical scenarios where the balance between bone formation and 
resorption is interfered by non-physiological conditions such as foreign material perturbations, 
loading stress exposures, and atypical hormone releases(5). Long term prognoses of joint 
arthroplasties suffer from osteolysis due to the joints’ exposure to routine mechanical loading 
and wear particle generation(7, 18, 19, 69). While several studies have investigated the 
individual effects of wear particle or mechanical perturbation on the cellular behaviors, the 
combinatory effects of both stimuli are not well studied. In this study, we examined the effects of 
mechanical strain, wear particles, and the combination of both on the inflammatory osteolysis. 





These cells were selected for this study since osteoblasts are derived from mesenchymal stem 
cells, and macrophages are largely responsible for bone remodeling. 
Ti induced inflammatory gene expressions were synergistically exaggerated by super-
physiologic equibiaxial strain in MC3T3-E1 cells. However, these gene expressions were not 
elevated in the Ti+SPS treated Raw264.7 cells. To investigate inflammatory responses, cells 
were exposed to Ti particles and equibiaxial strain. As described by other studies, equibiaxial 
strain under 5000µƐ was considered as normal physiologic strain, and strain between 5000-
30000 µƐ was considered as super-physiologic strain (80, 81). Due to unstable strain loading 
under 5000 µƐ with the Flexcell 4000T, we utilized 5000 µƐ strain as the minimum physiological 
strain level. Several studies have indicated that Ti treatment and mechanical loading induce 
inflammatory gene expressions (23, 83-86). Similar to these findings, we observed increased 
levels of Cox2, M-CSF, and IL-6 gene expression in MC3T3-E1 cells after Ti treatment. In 
RAW 264.7 cells, the gene expression of IL-1β and TNFα, as well as Cox2 and IL-6, increased. 
Cells were exposed to 0.05% (vol/vol) Ti for 3 h, because our dose and time-course experiments 
revealed that proinflammatory gene expression was maximal under this condition. Our previous 
studies showed that the ERK pathway is a key inflammatory cascade in the osteoinflammatory 
response (66, 87). The pERK protein expression analysis conducted in this study reflected a 
trend similar to that of the inflammatory gene expression data. 
To enhance the relevance of this study, we also tested primary calvarial osteoblasts and BMMs. 
Interestingly, inflammatory responses from primary cell lines were similar to those from 
MC3T3-E1 and RAW 264.7 cells. Ti increased inflammatory gene, as well as pERK, expression, 
in primary calvarial osteoblasts and BMMs. An increase in pERK and inflammatory gene 





were costimulated with SPS and Ti, responded differently, with no additional inflammatory 
response compared with the aforementioned cells. Our results imply that osteoprogenitor 
cells/osteoblasts may play more significant roles than macrophage-like cells/macrophages in 
responding to mechanical strain and may induce synergistic increases in inflammatory responses 
through the ERK pathway. We previously reported that wear particles accelerate actin 
remodeling, which leads to activation of the ERK pathway (66). Thus we further investigated 
whether wear particle-induced actin remodeling is affected by equibiaxial strain. Contrary to our 
hypothesis, quantitative analysis of particle internalization showed that actin cup formation was 
not affected by PS or SPS. 
Since wear particle internalization by actin remodeling was not affected by SPS, we 
further suspected that membrane damage caused by mechanical strain could be another source of 
increase in inflammatory gene and pERK expression. Membrane damage is known to elevate 
inflammatory gene expression through the ERK pathway (88, 89). Interestingly, SPS induced 
cellular membrane damage in MC3T3-E1 cells, while no membrane damage was observed in 
RAW 264.7 cells. For membrane damage analysis, we utilized the Sytox green assay. Since 
Sytox green stains the nucleus by entering the perforated membrane, membrane-damaged and 
dead cells could be detected using this system. To differentiate the true membrane-damaged cells 
from the dead cells, we performed the MTT assay, which measures the metabolic activity of 
cells. In MC3T3-E1 and RAW 264.7 cells, metabolic activities were decreased in the Ti and Ti + 
SPS groups compared with the no-treatment group. However, the Sytox green assay revealed 
increased cell membrane damage in MC3T3-E1 cells, which were treated with both stimuli. On 
the other hand, it only took Ti exposure to cause membrane damage similar to that in RAW 
264.7 cells. This difference may be due to differences in actin alignment between MC3T3-E1 
and RAW 264.7 cells. While the actin fibers in MC3T3-E1 cells were highly organized and 
aligned and appeared connected to both ends of the cell, the actin fibers in RAW 264.7 cells 





tensional forces. Cellular mechanical properties, such as stiffness and viscoelasticity, are 
regulated by membrane morphology established by actin stress fibers (90-92). Since actin fibers 
may need higher tension to maintain cell morphology in MC3T3-E1 than RAW 264.7 cells, they 
may be more susceptible to mechanical perturbation. We need to further investigate the various 
roles of actin in membrane damage caused by wear particles and mechanical perturbation. 
Furthermore, we examined the role of the ERK pathway in the inflammatory response triggered 
by the combination of wear particle exposure and strain. AZD significantly decreased pERK 
expression in the Ti, SPS, and Ti + SPS groups. These low pERK expressions resulted in a 
significant decrease in inflammatory gene expression in MC3T3-E1 and RAW 264.7 cells. 
Consistent with previous studies, our data support the idea that the ERK pathway could be an 
important therapeutic target for preventing inflammatory osteolysis (66). 
In summary, this study supports our hypothesis that 1) SPS synergistically increases 
inflammatory gene expression, which is induced by wear particles in osteoprogenitor 
cells/osteoblasts and 2) the ERK pathway is a key inflammatory cascade in MC3T3-E1 and 
RAW 264.7 cells. Our study is limited by the absence of other mechanical stimuli, such as 
compressive, bending, and torsional forces. Since cells are exposed to various mechanical 
perturbations in clinical scenarios, in-depth investigations of cellular responses to those 
mechanical stimuli are needed. However, we observed that osteoprogenitor cells are more 
susceptible to strain than are macrophages. Specifically, we highlighted the synergistic increase 
in pERK expression by actin remodeling by wear particles and membrane damage by mechanical 










Figure 2.1 Super-physiologic strain synergistically induces inflammatory gene expression 
with wear particles in MC3T3-E1 Cells . (A,B & C) Relative gene expressions of Cox2, 
MCSF, and IL6 in MC3T3-E1 cells are assessed. No treatment (N), Titanium (Ti), physiologic 
strain (PS), super-physiologic strain (SPS), Titanium + physiologic strain (Ti+PS), and Titanium 
+super- physiologic strain (Ti+SPS) groups were compared. All gene expression assay (n = 6 per 
group) is normalized by GAPDH. Each symbol denotes significant differences (P<0.05). (D) 
Immunoblot of MC3T3-E1 cells show the level of phosphorylation of ERK1/2 (phospho-p44, 






Figure 2.2 Mechanical strain does not induce significant changes of inflammatory 
responses from Raw264.7 Cells. Relative gene expressions of Cox2, IL6, TNFα and IL1β are 
assessed in Raw264.7 (A,B,C, & D). No treatment (N), Titanium (Ti), super-physiologic strain 
(SPS), and Titanium + super- physiologic strain (Ti+SPS) groups were compared. All gene 
expression assay (n = 6 per group) is normalized by GAPDH. Each symbol denotes significant 
differences (P<0.05) (E) Immunoblot of Raw264.7 cells demonstrates the level of 
phosphorylation of ERK1/2 (phospho-p44, phosphor-p42) after Ti particles stimulation 








Figure 3. Inflammatory Responses of Primary Calvaria Osteoblasts and BMMs to Ti 
particle, Super-Physiological Strain and Combination of Both (A&C) Immunoblot of 
primary calvarial osteoblasts and Bone marrow-derived macrophages show the level of ERK1/2 
phosphorylation (phospho-p44, phosphor-p42) after Ti particles stimulation with/without 
mechanical strain (30000 µƐ). n = 3 per group. Each symbol denotes significant differences 
(P<0.05).  (B&D) Relative gene expressions of Cox2, IL6, MCSF, TNFα and IL1β are assessed 
in primary calvarial osteoblast and bone marrow-derived macrophages. No treatment (N), 
Titanium (Ti), super-physiologic strain (SPS), and Titanium + super- physiologic strain 
(Ti+SPS) groups were compared. All gene expression assay (n = 6 per group) is normalized by 






Figure 2.4 Actin remodeling in MC3T3-E1 cells after Ti particles treatment with/without 
mechanical strain. (A) Actin dynamics including actin ring (O) and cup (U) formations are 
indentified through actin structure in axial, coronal, sagittal planes, and bright field. (B) The 
orientation of actin filaments in MC3T3 cells were compared in the no treatment, Ti, SPS, and 
Ti+SPS groups.  . Actin filaments of selected area (yellow square box) were magnified and 
projected into X-Y, X-Z and Y-Z planes to visualize actin remodeling. While No Treatment 
group shows actin fibers in alignment, active actin ring (white circle) and cup formations (white 
cup) are detected from Ti treated group. In the presence of SPS, MC3T3-E1 cells still maintain 
their actin fiber in alignment and active actin ring & cup formations. Scale bar in non-magnified 






Figure 2.5. Actin remodeling in Raw264.7cells after Ti particles treatment with/without 
mechanical strain. (A) Actin stress fibers are less organized in Raw264.7 cells, compared to 
MC3T3-E1 cells. Aggressive actin remodeling such as active actin ring (white circle) and cup 
formations (white cup) are detected from Ti treated group. SPS does not affect actin structure 
and remodeling for phagocytosis of wear particles. (B) The quantification analysis of cell 
associated with Ti particles is shown. The quantification of internalized Ti particles by counting 
actin rings shows no significant difference between the Ti group and the Ti +SPS treated group 






Figure 2.6 Wear particles and strain cause different levels of cell membrane damage in 
MC3T3-31 and Raw 264.7 cells.(A) Membrane damages of no treatment (N), Ti, SPS and 
Ti+SPS groups were assessed with sytox green assay. MC3T3-E1 cells demonstrate 
synergistically increased membrane damaged cell number in Ti+SPS group. Raw264.7 cells, 
however, show similar number of cell membrane damaged cells in Ti+SPS group, compared to 
Ti only treated group. (B) For both MC3T3-E1 and Raw264.7 cells, MTT assay shows similar 
level of metabolic activities in Ti only treated and Ti+SPS treated groups. Each symbol denotes 









Figure 2.7 The ERK pathway regulates inflammatory responses of MC3T3-E1 cells to wear 
particles and mechanical strain. (A) Selective inhibition of pERK1/2 by AZD in MC3T3-E1 
cells is assessed through immunoblot. AZD treatment blocks phosphorylation of ERK induced 
by Ti and mechanical strain.  (B, C & D) After AZD pretreatment, relative gene expressions of 
Cox2, MCSF and IL6 in MC3T3-E1 cells are assessed. No treatment, Ti, Ti+AZD, PS+AZD, 
PS+Ti+AZD, SPS+AZD, and SPS+Ti+AZD groups were assessed. All gene expression assay 







Figure 2.8 The role of ERK pathway as an inflammatory cascade in Raw264.7 cells. (A) 
Selective inhibition of pERK1/2 by AZD in Raw274.7 cells is assessed through immunoblot. (B, 
C & D) After AZD pretreatment, the relative gene expressions of Cox2, IL6, TNFα and IL1β are 
assessed in Raw264.7 cells with  no treatment, Ti, Ti+AZD, PS+AZD, PS+Ti+AZD, SPS+AZD, 
or SPS+Ti+AZD treatments.  All gene expression assay (with n=6 per group) is normalized by 









Chapter 3 Actin and ERK1/2-CEBPβ signaling mediates 
phagocytosis-induced innate immune response of osteoprogenitor 
cells 
3.1 Introduction  
Advances in biomaterials have led to an increased usage of bone and dental implants in 
clinical settings. Despite this popularity of the implants, clinical studies have shown that wear 
debris mediated inflammation leads to operative site pain, limitation of motion, osteolysis-
induced pseudarthosis, and, consequently, bone implant failure (5, 7, 69). Exposure to particulate 
wear debris influences host cellular responses including cell proliferation, apoptosis, osteogenic 
differentiation, and possible combinations of these factors (83, 93, 94). Due to the clinical 
significance, inflammation at host bone-implant interface has become an important scientific 
issue.  
 The culprit behind aseptic implant loosening is believed to be the wear particles such as 
titanium (Ti), polyethylene, and cobalt chromium.  These particles initiate phagocytosis through 
macrophages and monocytes, leading to a proinflammatory response (2, 3, 53). Macrophages and 
monocytes have efficient phagocytic receptors including Fcγ receptor and complement receptor 
3, which are activated upon particle binding. These activated receptors induce cellular signals 
which lead to remodeling of cytoskeletal elements, mainly actin, at the host-implant interface site 
of internalization (52, 57, 58). Macrophages and monocytes accumulate at the site of damage and 
secrete several inflammatory cytokines such as IL1β and TNFα, which significantly affect 
cellular behavior (27). These cytokines induce an imbalance between bone formation and 





TNFα, considerably altered IL6 and PGE2 levels are frequently detected in several pathological 
conditions such as osteoporosis and osteolysis around the bone implant (2, 74, 84).  
The primary function of osteoprogenitor cells, as a precursor of osteoblasts, is to form 
bone tissue that constitutes the skeletal system (97). Recent studies have highlighted additional 
roles of osteoprogenitor cells in the regulation of osteoclastogenesis by elaborating the function 
of RANKL and MCSF.  Since osteoprogenitors are resident cells at the host bone-implant 
interface, the fundamental questions arise as to the role of osteoprogenitor cells at the host bone-
implant interface and their ability to initiate a cascade of inflammatory response. Although many 
studies have examined the interaction between biomaterial debris and macrophages (2, 3, 53), the 
role of osteoprogenitor cells in biomaterials-related inflammation has not been extensively 
studied.  
The objectives of this study were to elucidate (1) the role of osteoprogenitor cells on 
metal particle-mediated osteolysis and (2) its phagocytic machinery in inflammatory cascade. To 
achieve the objectives, the responses of osteoprogenitors to Ti metal particles are explored 
through in vivo mouse calvaria model and in vitro experiments for elucidating inflammatory 
intracellular pathway.  
3.2Materials and Methods  
3.2.1 Study Design 
We utilized the mouse calvaria resorption model to study the role of osteoprogenitor cells 
in metal particle-mediated osteolysis.  In this model, Ti particles were implanted on the mouse 
pericranium, inducing an inflammatory response with osteolysis, which closely mimic the 





by immunohistochemical analyses.  Next, the intracellular mechanism of osteoprogenitor cells in 
the inflammatory cascade was further investigated.  We elucidated phagocytic capacity of 
osteoprogenitor cells by analyzing actin remodeling and investigated a key intracellular signal 
transduction process through Real time RT-PCR, ELISA, Western blot, and Immunostaining.   
 
3.2.2 Titanium Particles  
Commercially pure titanium particles (Ti) with an average diameter of 1-3μmwere 
purchased from Johnson Matthey Chemicals (Ward Hill, MA) as previously described by Ragab 
et al.(79) For removal of lipopolysaccharide (LPS), ten cycles of the following two steps were 
performed. In the first step, Ti particles were incubated in 25% nitric acid at room temperature 
for 20 hours followed by washing three times with phosphate-buffered saline (PBS). In the 
second step, the Ti particles were treated with a mixture of 0.1 N NaOH and 95% ethanol at 
30°C for 18-20 hours, followed by three times of washes with PBS between cycles. The 
endotoxin level was determined by a high-sensitivity version of the Limulus Amoebocyte Lysate 
assay (Biowhittaker, Walkersville, MD, USA) as previously described (i.e.<0.01EU/ml) (99).  
Prior to use, particles were sonicated for 15 minutes. 
 
3.2.3 Mouse Calvaria model  
For the in vivo study, Dr. Schwarz’s mouse calvaria resorption model was utilized with 
modifications.(98) Five 6-7weeks old male C57BL/6J mice were used in each group. They were 





mg of Ti particles in 0.5 ml of sterile phosphate buffered saline were spread on pericranium with 
subcutaneous injection. As a major component of the pericranium, osteoprogenitor cell is one of 
the first cell lines to be exposed to metal particles in this model.(100-102) Mice in the sham 
group underwent surgery without particle injection. Calvarial bones with pericranium were 
harvested after 1, 3 and 7 days. They were fixed with 4% paraformaldehyde at 4°C for 6 h, and 
were decalcified with 10% EDTA for 2 days. 5 μm thick paraffin embedded calvarial bones were 
prepared for immunohistochemistry. All procedures are approved by Institutional Animal Care 
and Use Committee (IACUC).  
 
3.2.4 Immunohistochemistry  
The primary antibodies used were phosphor-ERK1/2 antibody (Cell Signaling 
Technology, Danvers, MA), ERK1/2 antibody (Cell Signaling Technology, Danvers, MA), Cox2 
antibody (Cell Signaling Technology, Danvers, MA), IL6 antibody (Abcam, Cambridge, MA), 
and CD11b antibody (Abcam, Cambridge, MA) at a 1:50 dilution. Immuno-staining was 
performed using the HRP-ABC and HRP-DAB Cell & Tissue Staining Kits (R&D Systems, 
Minneapolis, MN). The calvarial sagittal suture line was stained using the Acid 
Phosphatase Leukocyte (TRAP) Kit (Sigma-Aldrich), and TRAP positive 
multinucleated osteoclast cells were counted under 10× magnification.(98) 
 
3.2.5 Cell Culture & Reagents  
To understand the inflammatory mechanism of osteoprogentitors, we investigated two 





induced into osteogenic differentiation and the murine pre-osteoblastic cell line MC3T3-E1. 
Human mesenchymal stem cells (hMSC) (Cambrex Inc., Walkersville, MD) were cultured in 
Mesenchymal Stem Cell Basal Media (MSCBM) containing mesenchymal cell growth 
supplement (MCGS), L-Glutamine, and penicillin-streptomycin (Lonza).  For osteoprogenitor 
differentiation, the medium was changed from M7SCBM to hMSC Differentiation Basal 
Medium-Osteogenic containing dexamethasone, L-Glutamine, Ascorbate penicillin-
streptomycin, MCGS, and β-Glycerophosphate.  The murine pre-osteoblastic cell line MC3T3-
E1 cells were purchased from American Type Culture Collection (ATCC; Manassas, MD, USA) 
and maintained in Minimum Essential Medium α (Invitrogen) supplemented with 10% fetal 
bovine serum (FBS; Gemini BIO) and 1% antibiotic/antimycotic (Gemini BIO) at 37°C and 5% 
CO2.  1x10
6
 differentiated hMSC or MC3T3-E1 cells were seeded on 10cm dishes two days 
before the Ti particle treatment. In order to examine the role of actin in phagocytosis, actin 
polymerization was blocked by cytochalasin D (CYD). Cells were treated with CYD for 30min, 
prior to the particle treatment.  AZD6244 (ARRY-142886), a potent, selective, and ATP-
uncompetitive inhibitor of MAPK/ERK kinase1/2 , was purchased from Selleck Chemicals 
(Houston, TX) and was used to treat the cells for 1 hour prior to the particle treatment. Cells 
were directly stimulated with Ti particles for 3 hours. Unattached particles were flushed by 
rinsing the plates 10 times with PBS followed by inverting the plates for 10 minutes to allow any 
residual unattached particles to be removed by gravity. 
 





For quantification of particle attachment, we increased the contrast between metal 
particles and entire cell surface by transfecting cells with GFP cDNA. Cells were seeded on 6-
well tissue culture plates and transfected with 2 µg of cDNA using the FuGene HD transfection 
reagent (Roche) according to the manufacturer’s instructions. The transfection efficiency was 
higher than 95%. A GFP fluorescence image obtained from fluorescence microscope (ZEISS) 
was used to portray the complete cell surface in green. An image from bright field microscopy 
view showed the Ti particles as dark hole. Using the GFP image as the threshold for the cell 
surface, a customized Java program analyzed the percentage of cell surface which occupied by 
Ti particles (dark spot). The area was calculated by summation of the total pixel area of the cell 
surface image and the Ti particle image. Twenty cells were tested. 
 
3.2.7 Quantification of Internalization of Ti Particles 
  To quantify particle internalization, actin of osteoprogenitor cells was stained with 0.5 
µM Alexa Fluor 488-conjugated phalloidin. (Molecular Probes, Eugene, OR)  3D images of 
GFP(+) actin stained cells were obtained with a confocal microscope with an axial slice 
thickness 0.22µm and reformatted in X, Y, and Z dimensions.  To distinguish completely 
phagocytosed (internalized) particles and membrane-bound particles, actin filaments in a 
selected area were magnified and reformatted into X-Y (Axial), X-Z (Coronal) and Y-Z 
(Sagittal) planes. While the internalized particles are fully covered by actin filaments in axial, 
sagittal, and coronal view (Ring pattern: O), membrane-bound particles show a hemisphere of 





internalization, we selected three-hundred cells that exhibited Ti attachment and counted the 
number of cells with internalized particles. 
 
3.2.8 RNA Isolation and Real-Time RT-PCR 
Immediately after the stimulation, total RNA was isolated from cells using RNeasy Mini 
Kit (Qiagen). The 260/280 absorbance ratio was measured for verification of the RNA purity. 
Single stranded cDNA was synthesized from total RNA with the SuperScript III system 
(Invitrogen). Realtime RT-PCR for each target was performed with LightCycler FastStart DNA 
Master
PLUS
 SYBR Green I (Roche) using the Realplex system (Eppendorf). Primers sets used 
were: for mouse-GAPDH, (5'-AGAACATCATCCCTGCATCC-3') and (5'-
AGTTGCTGTTGAAGTCGC-3'); for mouse-IL6, (5'-AAAGCCAGAGTCCTTCAGAG-3') and 
(5'-CTAGGTTTGCCGAGTAGATC-3'); for mouse-Cox2, (5'-
ACATCGATGTCATGGAACTG-3') and (5'-GGACACCCCTTCACATTATT-3'); for human-
GAPDH, (5'-GAAGGTGAAGGTCGGAGTC-3') and (5'-GAAGATGGTGATGGGATTTC-3'); 
for human-Cox2, (5'-GAGTACCGCAAACGCTTTATGCT-3') and (5'-
ACTGAATGAAGTAAAGGGACAGCC-3'). Human-IL6 primer was purchased. (santa cruz 
biotechnology, inc, Santa Cruz, CA). The thermal cycling conditions consisted of preheating (10 
min at 95°C) and 40 cycles of denaturation (15 sec at 95°C), annealing (15 sec at 60°C) and 
elongation (20 sec at 72°C). For each sample, mRNA levels of each gene were normalized to 
GAPDH levels. 
 





The Nuclear Extract Kit (Active Motif, Carlsbad, CA) was used to isolate nuclear and 
cytoplasmic extracts. These extracts were further homogenized by sonication for 15 min at a 
10% duty cycle and 4 °C (Sonifier 250; Branson, Danbury, CT). The samples were centrifuged 
at 10,000×g for 10 min, and the supernatant was collected for analysis. Protein quantification 
was performed using the BCA Protein Assay reagents (Pierce, Rockford, IL) and 20 μg of 
protein extract was used for Western blotting. Samples were run in 4–20% SDS-polyacrylamide 
gels (Invitrogen) and electrotransferred to PVDF membranes which were blocked and probed 
with primary antibodies; phospho-ERK (pERK), ERK (tERK), and phospho-CEBP-β (pCREB β)  
(Cell signaling, Cambridge, MA) overnight at 4 °C. Blots were washed of excess antibodies in 
Tris-buffered saline containing 0.1% Tween 20 (TBS-T) and with 10% FBS, the blots were 
probed with a HRP-conjugated secondary antibody (Cell Signaling Technologies, Beverly, MA), 
and the protein were detected using the enhanced chemiluminescence (ECL) reagents 
(Amersham Pharmacia Biotech, Piscataway, NJ). Membranes were stripped with Restore® 
Western blot stripping buffer (Pierce) and reprobed with Lamin A/C (Cell Signaling) and 
GAPDH (Chemicon, Temecula, CA) antibodies as loading controls. 
 
3.2.10 Immunocytochemistry  
 After AZD pretreatment and Ti stimulation, cells on 4-chamber slide glasses (BD) were 
fixed with 4% paraformaldehyde and ethanol, rinsed with PBS, and air-dried overnight for 
immunocytochemistry. The slides were incubated in a blocking solution containing 5% serum, 
washed, and incubated with Phospho-ERK antibody(Cell signaling, Cambridge, MA) overnight 





antibody conjugated with Alexa 488 (Invitrogen) for 2 hours and visualized using the Axiovert 
imaging system (Zeiss, Thornwood, NY). Images were analyzed with an NIH Image J program. 
 
3.2.11 ELISA 
With or without the CYD and AZD pretreatment, the cells were incubated with 0.05% v/v Ti for 
3, 6, and 24 hours. Then the medium was collected for ELISA.  Mouse IL6 and PGE2 ELISA kit 
(R&D system, Minneapolis, MN, USA) was used for a quantitative measurement. 
 
3.2.12 Statistical Analysis 
An one-way ANOVA was used to test for the effect of Ti, CYD, AZD, and combination 
effects on phagocytic activity and inflammatory gene expression.  Student-Newman-Kuels 
multiple comparisons tests were performed to check for significance between levels for each of 
the factors.  Statistical significance was taken as p < 0.05.  
3.3 Results 
3.3.1 In vivo Metal Particle Mediated Osteolysis in Mouse Calvaria model 
The effects of osteoprogenitor cells on inflammatory osteolysis were assessed through 
time-course experiment. Ti particles (Black Arrow) were implanted on pericranium (white 
arrow) and harvested on days 1, 3 and 7 after the operation (Fig 1.A).   Immunostaining of 
CD11b was performed to confirm the existence of macrophages in pericranium. Macrophages 





increase of macrophage accumulation was detected at the site of Ti particle implanted in day 7. 
As shown in Fig 1.C&D, the number of TRAP positive osteoclasts (red arrow) on calvaria also 
markedly increased from day 3 to day 7. All Sham groups of different days have an average of 
four TRAP positive osteoclasts around the suture line. pERK, Cox2, and IL6 immunostainings 
were conducted to evaluate the inflammation of pericranium. In the Ti treated group, significant 
elevation of pERK, Cox2, and IL6 was observed in the pericranium from day1. Steady increase 
of pERK (Brown) was detected until day 7. (Fig 2.A)  This elevation corresponds with the 
increasing level of Cox2 and IL6 expression between day 1 and day 7 (Fig 2.B&C).  
 
3.3.2 Capacity of Phagocytosis in Osteoprogenitor Cell 
To study the capacity of phagocytosis in osteoprogenitor cells, quantification of particle 
attachment on cell surface and internalization by actin remodeling were performed. Schematic 
diagram of cell surface occupied by particles when treated with Ti particles is shown in Fig 3.A. 
The custom-written JAVA program showed the Ti occupied area, which is compromised of 
attachment and internalization of Ti, increased in a dose-dependent manner (Fig 3.B). In the 
presence of CYD, the occupied area significantly decreased (Fig 3.B). Under fluorescence, actin 
staining revealed a significantly pronounced occurrence of Ti particle attachment on actin fibers 
(Fig 3.C). In the CYD treated group, a marked decrease of Ti particle attachment was detected. 
(Fig 3.C).   
Actin internalization of Ti particles was investigated via analysis of confocal images. The 
no treatment group showed actin stress fibers in alignment whereas the Ti treated group showed 





internalized particles were identified through actin ring formation (O in Fig 4B), and membrane 
bounded particles were identified through actin cup formation. (U in Fig 4.B) In the presence of 
CYD, actin filaments depolymerized and became disorganized (Fig 4.A). The axial view of the 
Ti+CYD group showed a similar sized single, dark hole. Most particles, however, were 
membrane bounded particles. (Fig 4.A) Among the cells that exhibited Ti attachment, 
approximately 50% of the cells internalized Ti particles in the Ti-only treated group, while only 
10% of the cells in the Ti+CYD group internalized the particles. (Fig 4.C)  
 
3.3.3 Induction of IL6 and Cox2 Gene Expression by Ti Particle Mediated-Actin Remodeling 
 
To investigate whether particle-mediated actin remodeling is involved in inflammatory 
gene expression, we assessed the relative mRNA expression of TNFα, IL1β, IL6, and Cox2 
using real time RT-PCR. Unlike macrophages, TNFα and IL1β mRNA levels were not affected 
by Ti and CYD treatment. (Fig 5.A) The IL6 and Cox2 mRNA levels, however, significantly 
increased with dynamic actin remodeling after particle stimulation in both MC3T3-E1 and 
hMSC-derived osteoprogenitors (hMSCs). (Fig 5.C&D) As both internalization and attachment 
of Ti particles significantly decreased by CYD, IL6 and Cox2 gene expression decreased to a 
basal level even in the presence of Ti particles. (Fig 5.C) Correspondingly, the phosphorylation 
of ERK was elevated by Ti particles but inhibited by CYD in a dose dependent manner. (Fig 
5.B) 
 





We further clarified whether a loss of ERK has a distinct role in the inflammatory 
response in osteoprogenitor cells. The phosphorylation of ERK in MC3T3-E1 and hMSCs  was 
inhibited by AZD. Cells treated with AZD exhibited a selective and drastic inhibition of the ERK 
phosphorylation (pERK) in both nucleus and cytoplasm. (Fig 6. B) Furthermore, AZD treatment 
decreased pERK level, which is induced by Ti particles in both MC3T3-E1 and hMSCs (Fig 
6.A). The level of pERK expression correlated well with Cox2 and IL6 expression in MC3T3-E1 
and hMSCs. Real time RT-PCR verified that Ti particles elevate the IL6 and Cox2 mRNA, while 
AZD pretreatment dramatically decreased the IL6 and Cox2 mRNA levels in the both MC3T3-
E1 and hMSCs. (Fig 6.C&D). 
 
3.3.5 Direct Effects of Cytochalasin D on the ERK Pathway Mediated-Inflammatory 
Responses 
 
To clarify that particle-mediated actin remodeling is the main cause of the pERK, the 
direct effects of CYD on ERK and IL6 & Cox2 mRNA expression were examined. LPS is an 
endotoxin which elicits strong immune responses in animal cells. Since LPS induces 
phosphorylation of ERK without actin dynamics, we assessed the unexpected effects of CYD on 
ERK, IL6, and Cox2 expression using LPS.  MC3T3-E1cells were exposed to LPS for 30, 60, 
and 180 minutes with and without CYD pretreatment. CYD neither decreased nor increased the 
phosphorylation of ERK, which was elevated by LPS. (Supplemtnet 1.A).  Under the same 







3.3.6 The Role of ERK1/2-CEBP/β Pathway in IL6 and Cox2 Gene Expression  
To investigate the ERK mediated inflammatory pathway in depth, we targeted C/EBP-β 
as a primary inflammatory transcription factor. Since immunocytochemistry analysis has shown 
that the phosphorylated-ERK (pERK) is located in both the nucleus and cytoplasm (Fig 6.B), we 
assessed the level of pERK and phosphorylation of C/EBP-β in the cytoplasm and nucleus, 
separately. Notably, when treated with Ti particle alone, MC3T3-E1 cells were found to up-
regulate production of phosphorylated C/EBP-β (pC/EBP-β) and ERK in nucleus. This particle-
mediated phosphorylated C/EBP-β was blocked by CYD and AZD, correlating with pERK 
expression (Fig 7.A).  
 Next, the levels of IL6 and PGE2 were measured by ELISA to assess the anti-
inflammatory effects of CYD and AZD. MC3T3-E1 cells were treated with Ti particles for three 
different time points (3hr, 6hr and 24hr) in the presence or absence of AZD and CYD 
pretreatment. Compared to the no treatment, the Ti treatment resulted in significant increase in 
IL6 and PGE2 production within 24 hours. The addition of AZD or CYD reduced the production 
of both IL6 and PGE2 at the 24hr point. (Fig 7.B&C) 
 
3.4 Discussion 
Osteolysis at the site of implant attachment is a multi-factorial problem. Particularly, 
imbalance of bone remodeling caused by wear particle around an implant is known to be a major 
cause of the osteolysis (69, 99). Since osteoblasts derived from mesenchymal stem cells are 
responsible for both initial osseointegration of implants and ongoing bone regeneration (103, 





several studies identified that wear particles have adverse effects on viability, differentiation, and 
osteogenic function of osteoprogenitor cells (94, 103, 105), the participation of osteoprogenitor 
cells in the inflammatory process is not well studied.  In this study, we investigated innate 
immune functions of osteoprogenitor cells in inflammatory osteolysis and focused on the 
molecular mechanisms of osteoprogenitors in the presence of wear particles. Ti particles, which 
are commonly generated from numerous orthopaedic prostheses such as metal-on-metal bearing 
surfaces, spine pedicular screws, and dental implants, are widely used for inflammation studies. 
Since our study is focused on the in-depth mechanism of cellular inflammatory response to metal 
particles, we used Ti particles for precise analysis compared to other inflammatory studies. 
Several studies have shown intense osteoclasogenesis and inflammation responses from 
mouse calvaria model (98, 106, 107).  Similar to these studies, our in vivo experiments also 
resulted in significant increase of  TRAP positive osteoclasts and resorption pits on the calvaria 
suture line after Day7.(Fig 1.C&D) We did not quantify osteolysis by calculating the suture area 
due to a wide range of variable normal suture area. Due to significant geometrical differences of 
the calvaria, considerable error in calculating suture area was observed. Interestingly, our time 
course experiments of in vivo mice calvarial model revealed that particle contacted 
osteoprogenitor cells are able to initiate inflammatory cascade without the help of macrophages. 
High levels of pERK, Cox2, and IL6 expression were observed from Day 1 and steadily 
increased until Day7. The early increased levels of IL6 and Cox2 were involved predominantly 
in a late increase in number of osteoclasts and macrophages in Day7. (Fig1,8&9) IL6 and Cox2 
driven-PGE2 are known to recruitment macrophages and to accelerate the induction of IL1β and 
TNFα secretion in monocytes and macrophages, leading to osteoclast formation (108-112). In 





osteoprogenitor cells exaggerate the macrophage mediated-osteolysis by promoting osteoclast 
differentiation and assisting macrophage accumulation.  
As other studies indicated, we also confirmed that osteoprogenitor cells engulf metal 
particles and induce pro-inflammatory cytokines (94, 113, 114). Osteoprogenitor cells are 
capable of phagocytosing metal particles with dynamic actin remodeling. In this study, we 
identified that actin mediated phagocytosis results in activation of ERK pathway, leading to 
expression of inflammatory mediators. More specifically, IL6 and Cox2 expressions were found 
to be the end result of this ERK pathway. Similar to macrophages (87), inhibition of ERK 
pathway using AZD decreased inflammatory responses of osteoprogenitor cells. (Fig6) 
Interestingly, these phagocytosed particles increase IL6 and Cox2 gene expression in 
osteoprogenitor cell, while IL1β and TNFα.gene expression was not affected by particles. Since 
C/EBP-β has downstream effects on the production of inflammatory gene expression such as IL6 
and Cox2 (115-117), we targeted C/EBP-β as a key transcription factor in metal particle 
mediated inflammatory response.  Our immunoblot and immunocytochemcal analyses 
demonstrate that pERK is located in the nucleus and cytoplasm leading to phosphorylation of 
C/EBP-β, which is a transcriptional factor of IL6 and Cox2. (Fig 6.B&8.A) These results 
indicate that ERK_ C/EBP-β pathway acts as a link between metal particle phagocytosis and 
inflammatory gene expression. Schematic illustration of the proposed intracellular signal 
pathway is given in Figure 10. The detailed receptor for metal particle await further 
investigation, but we can speculate that the osteoprogenitor cells might have an unrecognized 
innate immune receptors associated with actin-mediated phagocytosis and inflammatory 







Figure 3.1 In vivo time course experiments of Ti particle induced osteolysis.   
Four different groups of mice calvarium were used for histology analyses; Sham, 1 day Ti 
treated, 3 days Ti treated, and 7 days treated groups. Ti particles (black arrow) were implanted 
on pericranium (white arrow). All sections of each group were stained with Tri-chrome(top row, 
A), CD11b (2
nd
 row, B), and TRAP (3
rd
 row, C).  (A) Tri-chrome sections were photographed at 
10X magnification. (B) CD11b positive cells in pericranium were observed at 40X 
magnification. (C) TRAP positive osteoclasts (red arrow) at suture line were detected at 40X and 







Figure 3.2 In vivo inflammatory responses of pericranium to Ti particle.   
To investigate the effects of inflammation on osteoclastogenesis, same four groups were used for 
histology analyses: Sham, 1 day Ti treated, 3 days Ti treated, and 7 days treated groups. All 
sections of each group were stained with (A) pERK, (B) Cox2, and (C) IL6. The expressions of 








Figure 3.3 Attachment of Ti particles on cell surface.  
(A) The schematic of a customized JAVA program for quantification of Titanium (Ti) particle-
occupied area on the cell surface is shown. (B) Percentage of Ti-occupied area out of total cell 
surface is generated based on images from the JAVA program. Different dose of Ti particles 
were treated to MC3T3-E1 cells with/without 10µm of the Cytochalasin D (CYD) pretreatment. 
n=20. (C) Actin fluorescent image analysis of particle-occupied area illustrates that Ti particles 
(Bright View) are accumulated along with actin filaments (Fluorescent image) and 10µm of 








Figure 3.4 Actin remodeling for phagocytosing of Ti particles in osteoprogenitor cell.  
(A) Actin filaments of selected area (yellow square box) were magnified and projected into X-Y, 
X-Z, and Y-Z planes by confocal microscopy to visualize actin remodeling. No treatment, Ti, 
CYD, and Ti+CYD group were compared. Scale bar in non-magnified images is 10µm. Scale bar 
in magnified images is 1µm. (B) After Ti treatment, vigorous dynamics including actin ring (O) 





µm. (C) The quantification analysis of cell associated with Ti particles is shown. Each group has 





























Figure 3.5 Ti particle mediated-actin remodeling activates the ERK pathway to induce 
inflammatory gene expression in MC3T3-E1 and hMSC-derived osteoprogenitor cells.  
(A) Relative gene expressions of TNFα and IL1β in MC3T3-E1 cells are assessed. No treatment 
(N), Titanium (Ti), Cytochalasin D (CYD), and Cytochalasin D + Titanium (Both) groups were 
compared. (B) Immunoblot of MC3T3-E1 cells show the level of phosphorylation of ERK1/2 
(phospho-p44, phosphor-p42) after stimulation of Ti particles with/without CYD. (C&D) 
Relative gene expressions of IL6 and Cox2 in MC3T3-E1 and hMSC-derived osteoprogenitor 
cells are assessed. Every gene expression assay is normalized by GAPDH and n=6. Each symbol 






Figure 3.6 ERK cascades is a key inflammatory pathway in osteoprogenitor cells. (A) 
Selective inhibition of pERK1/2 by AZD is assessed through immunoblot. (B) pERK fluorescent 
image analysis illustrates that (pERK) expression can be induced by titanium particle in MC3T3-
E1 and hMSC-derived osteoprogenitor cells.  These pERK expressions are also located in both 
the nucleus and cytoplasm.  AZD treatment blocks phosphorylation of ERK expression in both 
the nucleus and cytoplasm. (C&D) Relative gene expressions of IL6 and Cox2 in MC3T3-E1 
and hMSC-derived osteoprogenitor cells are assessed. No treatment (N), Titanium (Ti), AZD 
(AZD), and AZD + Titanium (Both) groups were compared. Every gene expression assay is 








Figure 3.7 The ERK pathway mediates phosphorylation of CCAAT/enhancer-binding 
protein beta (CEBP- β) for inflammatory response to Ti particles.  
(A) Immunoblot of the cytoplasm and nucleus shows phosphorylated ERK1/2 (phospho-p44, 
phospho-p42), phosphorylated CEBP-β (phosphor-CEBP-β), GAPDH, and Lamin A/C after Ti 
particle stimulation with/without AZD or CYD in MC3T3-E1 cells. Effective separations of 
nuclei and cytoplasm have been confirmed by GAPDH and Lamin A/C detection. (B&C) 
Prostaglandin E2 (PGE2) and IL6 secretion is measured by ELISA. MC3T3-E1 cells were 























Figure 3.8. Model for mechanism of inflammatory responses to Ti particles in progenitor 

















Figure 3.9 Cytochalasin D has no direct effects on the ERK pathway mediated-
inflammatory responses. 
(A) CYD neither decreases nor increases phosphorylation of ERK1/2 which is elevated by 
Lipopolysaccharide (LPS). Total ERK (t-ERK) was examined as a loading control. (B&C) 
Selectivity of CYD is assessed through relative gene expressions of IL6 and Cox2 in MC3T3-E1 
cells. Every gene expression assay is normalized by GAPDH and n=6. Each symbol denotes 






Chapter 4. Osteogenic Cells Orchestrate Macrophage Migration 
and Osteoclastogenesis through ERK-CEBP/b pathway mediated 
Cox2, MCSF, IL6 and MCP1 secretion  
4.1 Introduction  
As the osteoimmunology niche emerges, crosstalk between immune and skeletal system 
has been investigated mechanistically and clinically for inflammatory diseases (118). Bone 
cavity is a reservoir for hematopoietic stem cells (HSCs), which are major sources for immune 
system (28). Recent studies have shown that bone cells provide key molecules and differentiate 
HSCs into immune lymphocytes (28). Likewise, immune cells involves in bone homeostasis by 
secreting key cytokines which regulate bone cells’ activities (119, 120). The immune cells also 
share common precursors such as monocytes and macrophages with bone cells. In addition to 
their immune function, matured macrophages and monocytes are able to differentiate into 
osteoclasts (50).  
Due to its clinical significance, the interaction between immune and bone cells has been 
an important issue in orthopaedic fields for long-term success of arthroplasties. The culprit 
behind failed arthroplasties is believed to be the wear particles induced inflammatory osteolysis 
at the interface between bone and implant (121). Wear particles are constantly induced from the 
bearing surfaces and surfaces of the prostheses. Since various materials such as Titanium (Ti), 
Cobalt-chromium (Co-Cr) alloy, and polyethylene are used for bone implants, different types 
wear particles are generated (93, 122-124). Macrophages have been studied for decades as one of 
the most important inflammatory mediators in orthopaedic field. Macrophages and monocytes 





particles accelerates inflammatory cytokines release such as RANKL, TNFa, and ILs from 
macrophages, leading to osteoclastogenesis (2, 8, 17, 56, 75). Effects of wear particles on 
osteogenic lineage also have been studied regarding its viability, and bone forming activities 
(108, 114, 125). Although there is growing evidence that bone-forming cells may facilitate host 
defenses and disease progression (126), surprisingly few studies have been focused on role of 
osteogenic lineage in immune system.  Our previous study that Ti treated osteogenic lineage 
engulfed metal particles and induced inflammatory cytokines raises the question of their 
interaction with immune cells. For this reason, we investigated (1) effects of inflammation from 
osteogenic cells on macrophages. (2) Cellular mechanisms of the crosstalk and their therapeutic 
potential were also assessed. To achieve the objectives, we employ osteogenic lineage specific 
MEK1 dominant negative mice (CRE/dn-MEK1) and explore inflammatory responses though in 
vivo/in vitro experiments.  
 
4.2Materials and Methods 
4.2.1 Osteogenic cells-specific MEK1 dominant negative ERK defective mice  
We employed an osteogenic cells - specific dominant negative MEK1 mouse. This new 
line of mice was generated by crossing the following two transgenic lines:  Parent Line 1 express 
dominant-negative mutant of MEK1 following Cre-mediated removal of the upstream "loxP-
STOP-loxP" cassette (WT/dn-MEK1, Jackson Laboratory). Parent Line 2 is another knock-in 
mice which carries both tTA under the regulation of the osterix promoter and, just downstream, a 
tetracycline responsive element (TRE; tetO)-controlled GFP/Cre fusion protein (CRE/WT). The 
distribution of GFP/Cre fusion protein was limited to primary spongiosa, cortical bones and the 





cell-specific dominant negative MEK1 in which ERK1/2 activation is dysfunctional. We 
confirmed the genetic traits by genotyping. Primers are as follows; Cre (5’-
GCGGTCTGGCAGTAAAAACTATC-3’ and 5’-GTGAAACAGCATTGCTGTCACTT-3’), IL-
2 (5’- CTAGGCCACAGAATTGAAAGATCT-3’ and 5’-
GTAGGTGGAAATTCTAGCATCATCC-3’), MEK1DN (5’-
GTGAAGGAACCTTACTTCTGTGGTG-3’ and 5’-GTCCTTGGGGTCTTCTACCTTTCTC-
3’) and TCR delta (5’- CAAATGTTGCTTGTCTGGTG-3’ and 5’-
GTCAGTCGAGTGCACAGTTT-3’). PCR was performed in 10  minutes of 94 °C and 40 cycles 
of 30 seconds of 94 °C, 30 seconds of 55 °C and 1 minute of 72°C. The PCR products were 
analyzed by 2% agarose gel electrophoresis.  
 
4.2.2 In vivo Mouse Calvaria model  
For the in vivo study, Dr. Schwarz’s mouse calvaria resorption model was utilized with 
modifications. Five 10-12 weeks old male C57BL/6J mice (WT/WT) were used in each group. 
They were anesthetized with 80 mg/kg of ketamine and 7 mg/kg of xylazine by intraperitoncal 
injection. 30 mg of Ti particles with/without 50mg/kg of AZD6244 (ARRY-142886) in 0.5 ml of 
sterile phosphate buffered saline were spread on pericranium with subcutaneous injection. Ti 
particles were implanted on the pericranium layer without an invasive incision to avoid wound 
induced-inflammation. As a major component of the pericranium, osteogenic cells are one of the 
first cell lines to be exposed to metal particles in this model. Mice in the sham group underwent 
surgery without particle injection. Calvarial bones with pericranium were harvested after 1, 3 and 
7 days. They were fixed with 4% paraformaldehyde at 4°C for 6 h. Samples were preserved in -





scanner (SkyScan 1172D, Kontich, Belgium) with 27 x 27 x 27um
3 
scanning and reconstruction 
voxel size. Calvaria samples were observed at a voltage of 70kV, a current of 11uA, and 0.4º 
degree of rotation step. A heuristic algorithm was used to eliminate non-bone voxels. Three-
dimensional images were obtained using Image J software. Samples for histology analysis were 
decalcified with 10% EDTA for 2 days. 5 μm thick paraffin embedded calvarial bones were 
prepared for immunohistochemistry. All procedures are approved by Institutional Animal Care 
and Use Committee (IACUC).  
 
4.2.3 Cell Culture & Reagents  
The C57BL/6J mice were purchased from The Jackson Laboratory. Bone marrow-
derived macrophages (BMMs) were prepared as described. The non-adherent fraction of mouse 
bone marrow cells was cultured in Minimum Essential Medium (MEM) α (Invitrogen) 
supplemented with 10% fetal bovine serum (FBS; Gemini Bio), 1% antibiotic/antimycotic 
(Gemini Bio) and 10 ng/ml of recombinant mouse M-CSF (R&D). The resulting adherent cells 
were taken to represent purified BMMs. Purified primary BMMs were then cultured in serum-
free MEMα supplemented with M-CSF. Animal experiments were approved by the Institutional 
Animal Care and Use Committee of Columbia University (Protocol No. AC-AAAA8363). 
Primary bone cells were isolated from calvarie under sterile conditions immediately after 
sacrifice as described. Calvarie were harvested under sterile condition and were cut into small 
pieces out for migration of osteogenic cells. Soft tissues were removed by incubating the bone 
chips in collagenase solution for 2 hours in a 37c water bath. The bone chips were transferred 





(Gibco), 1% of penicillin /streptomycin (Gibco), gentamycin (Gibco), fungizone (Gibco), and 
ascorbate (Gibco)) and cultured until cells migrating from the bone chips reached approximately 
80% confluency. 
 
4.2.4 Titanium Particles  
Commercially available pure titanium particles (Ti) with an average diameter within 0.3-
1μm, were purchased from Johnson Matthey Chemicals (Ward Hill, MA) as previously 
described by Ragab et al.(79)  To remove endotoxin from the particles, ten cycles of the 
following two steps were performed.  In the first step, Ti particles were incubated in 25% nitric 
acid at room temperature for 20 hours followed by washing three times with phosphate-buffered 
saline (PBS).  In the second step, the Ti particles were treated in a mixture of 0.1 N NaOH and 
95% ethanol at 30°C for 18-20 hours, followed by five time-washes with PBS between cycles. 
The endotoxin level was determined by Limulus Amebocyte Lysate kit (i.e.<0.01EU/ml).  Prior 
to use, particles were sonicated for 15 minutes to avoid particle aggregation.  Cells were directly 
stimulated with Ti particles for 3 hours. Unattached particles were flushed by rinsing the plates 
10 times with PBS, followed by inverting the plates for 10 minutes to allow any residual 
unattached particles to be removed by gravity. 
 
4.2.5 RNA Isolation and Real-Time RT-PCR 
Immediately after the stimulation, total RNA was isolated from cells using an RNeasy 
Mini Kit (Qiagen).  The 260/280 absorbance ratio was measured for verification of the purity of 





(Invitrogen). Realtime RT-PCR for each target was performed with LightCycler FastStart DNA 
Master
PLUS
 SYBR Green I (Roche) using the Realplex system (Eppendorf). Primers sets used 
were: for mouse-GAPDH, (5'-AGAACATCATCCCTGCATCC-3') and (5'-
AGTTGCTGTTGAAGTCGC-3'); for mouse-IL6, (5'-AAAGCCAGAGTCCTTCAGAG-3') and 
(5'-CTAGGTTTGCCGAGTAGATC-3'); for mouse-Cox2, (5'-
ACATCGATGTCATGGAACTG-3') and (5'-GGACACCCCTTCACATTATT-3'); 
for mouse-IL1b (5'-CCTGTGTAATGAAAGACGGC-3'), and (5'-
GGAAGACACAGATTCCATGG-3'); for mouse-TNFa, (5'-GTTCTCTTCAAGGGACAAGG-
3') and (5'-TGACTCCAAAGTAGACCTGC-3'); for mouse-MCSF,  (5'-
AAGAGAAGTACCAGGGATCG-3'), and (5'-TCCAATGTCTGAGGGTTTCG-3'). The 
thermal cycling conditions consisted of preheating (10 min at 95°C), 40 cycles of denaturation 
(15 sec at 95°C), annealing (15 sec at 60°C), and elongation (20 sec at 72°C).  For each sample, 
mRNA levels of each gene were normalized to GAPDH levels. 
 
4.2.6 Protein Isolation & Western Blot Analysis 
The Nuclear Extract Kit (Active Motif, Carlsbad, CA) was used to isolate nuclear and 
cytoplasmic extracts. These extracts were further homogenized by sonication for 15 strokes at a 
10% duty cycle and 4 °C (Sonifier 250; Branson, Danbury, CT). The samples were centrifuged 
at 10,000×g for 10 minutes, and the supernatant was collected for analysis. Protein quantification 
was performed using the BCA Protein Assay (Pierce, Rockford, IL) reagents, and 20 μg of 
protein extract underwent Western blotting. Samples were run in 4–20% SDS-polyacrylamide 





with primary antibodies overnight at 4 °C. Excess antibodies were washed off from the blots 
with Tris-buffered saline containing 0.1% Tween 20 (TBS-T) and with 10% FBS.  Blots were 
furtherprobed with a HRP-conjugated secondary antibody (Cell Signaling Technologies, 
Beverly, MA), and detected using the enhanced chemiluminescence (ECL) reagents (Amersham 
Pharmacia Biotech, Piscataway, NJ).  Membranes were stripped with Restore® Western blot 
stripping buffer (Pierce) and reprobed with GAPDH (Chemicon, Temecula, CA) antibodies as 
loading controls. 
 
4.2.7 Immunocytochemistry  
 After AZD pretreatment and Ti stimulation, cells on 4-chamber slide glasses (BD) were 
fixed with 4% paraformaldehyde and ethanol, rinsed with PBS, and air-dried overnight for 
immunocytochemistry. The slides were incubated in a blocking solution containing 5% serum, 
washed, and incubated with Phospho-ERK antibody(Cell signaling, Cambridge, MA) overnight 
at 4 °C. The slides were then washed and incubated with a goat anti-rabbit IgG secondary 
antibody conjugated with Alexa 488 (Invitrogen) for 2 hours and visualized using the Axiovert 
imaging system (Zeiss, Thornwood, NY). Images were analyzed with an NIH Image J program. 
4.2.8 Confocal Microscopic Imaging  
  After the Ti treatment and strain stimulation, 3D images of GFP(+) actin stained cells 
were obtained with a confocal microscope (axial slice thickness of 0.22µm, reformatted in X,Y, 
and Z dimensions). To study actin remodeling, actin filaments in a selected area were magnified 
and reformatted into X-Y (Axial), X-Z (Coronal), and Y-Z (Sagittal) planes. 3D imaging allowed 





membrane-bounded particles. While the internalized particles are fully covered by actin 
filaments in all views (Ring pattern: O), partially phagocytosed particles show a hemisphere of 
actin filaments in the sagittal and coronal view (Fig 3, Cup pattern: U). For quantitative analysis 
of phagocytosis, we selected a hundred cells that exhibited Ti attachment and counted the 
number of cells with internalized particles. 
4.2.9  Co-Culture 
Double tray co-culture system (milipore) for osteogenic cells and BMMS was used to 
examine whether ERK pathway inhibition in osteogenic cells interferes affects with BMMs gene 
and protein expression. BMMs cells were seeded on hanging inserts (pore size 1um) which allow 
cells to access media without direct contact to osteogenic cells on basolateral side. Osteogenic 
cells from WT and ERKdef mice were treated with Ti particles for 24hrs. After 24hr incubation, 
BMMs were harvested for RT-PCR and western blot analysis   
4.2.10 In vitro Migration Assay 
Migration of BMMs was measured in a migration chamber, based on the Boyden 
chamber principle. Chemicon QCM  migration kit with 5 um porous membrane was used. 
Osteogenic cells from WT or ERKdef mice were loaded in the lower chamber with medium. 
BMMs were placed in insert transwell with medium. After 24 hr Ti treatment to osteogenic cells, 
non-migrated cells on the upper side of membranes were removed. Migrated cells on the lower 
side of the membrane were stained with DAPI. The number of migratory cells was determined 
by relative  fluorescence. Medium containing 10ng/ml MCP-1in lower chamber was used as a 
positive control.   





An one-way ANOVA was used to test for the effects of Ti, AZD6244, and combination 
effects on phagocytic activity and inflammatory gene expression.  The significance between 
levels for each of the factors was checked with Student Newman-Kuels multiple comparisons 
tests.  Statistical significance was taken as p < 0.05.  
 
4.3 Results 
4.3.1 Inflammatory Responses of Osteogenic Lineage Specific-ERK-def Mice to Metal 
Particles  
The inflammatory responses of WT/WT, CRE/WT, WT/dn-MEK1 and CRE/dn-MEK1 
mice to Ti particles were assessed through this mouse calvaria in vivo model. No distinctive 
differences were observed in bone morphology (Fig1.A). All groups also showed similar 
phenotypes including bone length and number of TRAP-positive osteoclasts in femur and 
calvaria(Fig.1.A&B).  Inhibition of pERK expression in pericranium of CRE/dn-MEK1 was 
confirmed through immunostaining (Fig. 1.C). 
Ti particles were implanted on pericranium and harvested 7 days post-op (Fig 1.B). H&E 
staining was performed to confirm the Ti particles mediated osteolysis by histomorphometry. 
Severe osteolysis was detected at the site of Ti particle implantion in the WT, CRE, and MEK 
groups. As shown in Fig 1.C&D, the number of TRAP positive osteoclasrs (white arrow) on 
calvaria also significantly increased in Ti treated WT/WT, CRE/WT and WT/dn-MEK1 mice. In 
contrast, Ti induced osteoclastogenesis and osteolysis were markedly decreased inCRE/dn-





For the precise evaluation of wear particles effects on calvaria, 3D images of mice 
calvaria were obtained with a uCT and reformatted into X-Y (Axial), X-Z (Coronal) and Y-Z 
(Sagittal) planes.  CRE/dn-MEK1 mice showed strikingly less bone defects and inflammatory 
osteolysis at the site of Ti particle implanatation, compared to Ti particle treated WT/WT, 
CRE/WT, and WT/dn-MEK1 mice.  
Expression of inflammatory mediators (Cox2, IL6) and an osteoclastogenic marker 
(MCSF) were evaluated..Three groups were tested in these experiments: WT/WT_Sham, 
WT/WT_Ti, and CRE/dn-MEK1_Ti. While Ti treatment increased expression of IL6 in the 
WT/WT group, significantly decreased expression of the inflammatory mediators was detected 
(Fig 2.C&D). Sham groups of CRE/dn-MEK1 mice showed similar levels of inflammatory gene 
expression as the WT_Sham group (Data not shown). Similar trends were observed in MCSF 
staining. The Ti treated group showed an increased number of MCSF positive osteogenic cells 
and macrophages. In contrast, CRE/dn-MEK1 mice showed decreased osteoclastogenic markers 
after Ti treatment( Fig. 2.C). 
4.3.2 Characterization of Osteogenic Cells from CRE/dn-MEK1 Mice 
We used western blot and immunocytochemistry analysis to assess inhibition of pERK 
expression in primary bone cells from CRE/dn-MEK1 mouse. Ti stimulation of primary bone 
cells harvested from WT mice significantly increased the pERK expression whereas the 
stimulation did not affect the primary bone cells from CRE/dn-MEK1 mice(Fig 3.A&B). GFP 
and pERK expression levels were also evaluated to confirm that pERK expression is inhibited in 





Next, phagocytic activity of CRE/dn-MEK1 osteogenic cells were examined through 
confocal microscopy.  In our previous study, we used a novel method to quantify actin-mediated 
phagocytosis (21). Completely internalized particles were identified by their actin-ring 
appearance , and membrane-bound particles were identified by actin-cup appearance. Using this 
method, we detected actin- cup and ring formation in Ti-treated primary osteogenic cells from 
WT/WT and CRE/dn-MEK1 mice (Fig 3.C). As shown in our previous study, actin fibers in the 
no treatment group were highly organized in a uniform alignment(data not shown). Primary bone 
cells from both WT/WT and CRE/dn-MEK1 mice were able to engulf fluorescent beads and 
exhibited disorganized actin filaments with actin- cup and ring formation. Fluorescent beads 
were internalized in approximately 50% of the cells that exhibited Ti attachment in the WT/WT 
and CRE/dn-MEK1 groups. There were no visible quantitative changes in the actin structure of 
WT/WT and CRE/dn-MEK1 cells.  
4.3.3 Inflammatory Gene Expreesion is Regulated by ERK Pathway 
To further elucidate the role of ERK in inflammatory osteolysis, the effects of wear 
particles and LPS treatment on primary osteogenic cells from CRE/dn-MEK1 mice were 
examined. Osterix and osteocalcin mRNA expression were measured to assure the purity of 
isolated primary osteogenic cells. Osteogenic cells from both WT/WT and CRE/dn-MEK1 mice 
exhibited high levels of osterix and osteoclacin mRNA expression compared to BMMs (Fig 
4.A). Real-time RT-PCR data verified that Ti particles and LPS treatment elevated IL-6, M-CSF, 
Cox2, and MCP-1 mRNA expression in osteogenic cells from WT/WT mice, while these 
treatments dramatically decreased the levels of expression of these inflammatory genes in 





To investigate the ERK-mediated inflammatory pathway in-depth, we targeted C/EBP-β 
as a primary inflammatory transcription factor. We assessed the level of pERK and 
phosphorylation of C/EBP-β in primary osteogenic cells from WT/WT and CRE/dn-MEK1 
mice. Notably, when treated with Ti particles alone, the osteogenic cells were found to up-
regulate production of phosphorylated C/EBP-β (pC/EBP-β) and ERK. This particle-mediated 
phosphorylated C/EBP-β was strikingly decreased in osteogenic cells from CRE/dn-MEK1 mice 
(Fig 4.C); The level of pERK expression and pCEBP/b correlated well with these inflammatory 
gene expressions (Fig 4).  
 
4.3.4 Osteogenic cells Orchestrate Inflammatory Responses with Macrophages  
To further investigate the impact of osteogenic cells on other immune cells, we assessed 
inflammatory gene expression and migration of BMMs that were co-cultured with osteogenic 
cells using the transwell system. BMMs were seeded on insert wells and co-cultured with Ti 
treated osteogenic cells without direct contact. BMMs were harvested 24 hours after the Ti 
treatment for rea-ltime RT-PCR analysis. BMMs showed significantly increased TNFα and IL1β 
expression when they were co-cultured with Ti treated osteogenic cells from WT mice. In 
contrast, osteogenic cells from CRE/dn-MEK1 mice had no siginificant impact on TNFα and 
IL1β mRNA expression of BMMs (Fig 5.A&B).     More description about other gene 
expression  
Interestingly, H&E images revealed far more cell infiltration at the site of Ti particle 
implantation in WT/WT, CRE/WT, and WT/dn-MEK1 mice, compared to CRE/dn-MEK1 





migration, was down-regulated in CRE/dn-MEK1 osteogenic cells (fig 5.D). Thus, we next 
investigated the role of osteogenic cells on migration of macrophages. First, we tested whether 
pERK inhibition decreased migration of BMMs in vitro using a modified Boyden chamber 
system. We obtained fluorescent images of migrated BMMs’ nuclei by staining the bottom side 
of insert membrane (Fig 6.A). We also utilized fluorescence plate reader for precise 
quantification. Both image and fluorescence quantification analyses showed that Ti induced 
BMMs migration was down-regulated in the co-culture system with CRE/dn-MEK1 cells (Fig 
6.A). The effects of osteogenic cells on migration of macrophages were also assessed through 
time-course In vivo experiment. Few CD11b and MCP1 positive cells were not observed in the 
pericranium in WT/WT and CRE/dn-MEK1mice in Day 0. MCP positive cells started to increase 
1 day after Ti treatment leading to significant increase of macrophage accumulation at the site of 
Ti particle implanted from day 3 to day 7 in WT group. In contrast,  as shown in Fig 6.C, 
CRE/dn-MEK1 mice showed strikingly less MCP1 expression level and CD11b positive cell 
accumulation from day 1 to day 7 (Fig 6.C).   
4.3.5 Therapeutic Potential of ERK Inhibitor for Inflammatory Osteolysis 
We have shown that activation of the ERK signaling pathway is required for an 
inflammatory response in osteoprogenitor cells. Thus, therapeutic effects of ERK inhibitors on 
preventing Ti particle-mediated osteolysis were investigated through an in vivo model. 
Expression of inflammatory mediators (Cox2, IL6, pERK) and osteoclastogenic genes (TRAP, 
CD11b) were evaluated. Four groups were tested in this experiments: Sham, Ti_Day7, 
AZD_Day7, and Ti+AZD_Day7. Consistent with our time course experiment, Ti treatment 
increased expression of pERK, Cox2, and IL6. AZD treatment significantly decreased the 





level of inflammatory expression as the AZD-only treated group. Similar trends to inflammatory 
responses were observed in TRAP and CD11b staining. The Ti-treated group showed increased 
numbers of TRAP positive osteoclasts and macrophages. AZD treatment markedly decreased 
osteoclastogenesis induced by Ti treatment. (Fig 7.D&8) 
4.4 Discussion  
Immune responses are essential processes that protect the human body from foreign 
infection.  However, excessive immune responses result in massive inflammation and destruction 
of healthy tissues. In orthopaedic fields, the duality of immune responses has been an issue for 
successful arthroplasties. The articulating motion of joint implants on the bearing surfaces and 
non-articulating surfaces of prostheses continuously produce wear particles (127). The generated 
wear particles trigger massive immune responses leading to inflammatory osteolysis (7). Many 
different types of cells including monoctyes, macrophages, osteoblasts, osteoprogenitors, 
chondrocytes, and fibroblasts, are exposed to the wear particles and in turn express inflammatory 
responses (5, 8, 128-130). Macrophages have been considered as key immune cells that set in 
motion osteoclastogenesis and implant failure (17, 130, 131). Reported studies have shown that 
macrophages phagocytose various sizes of Ti, Co-cr, and polyethylene particles and regulate 
bone homeostasis by secreting inflammatory cytokines such as Tumor necrosis factors (TNFa) 
and IL1b (57, 63, 132, 133). Although osteogenic cells, including osteoprogenitors, osteoblasts, 
and osteocytes, are largely responsible for bone homeostasis and are impacted by wear particles, 
their innate immune responses to wear particles are not fully studied. In this study, we explored 
the immune responses of osteogenic cells to Ti particles and their role in inflammatory osteolysis 





In this study, we discovered that osteogenic cells engulf Ti particles through phagocytic 
machinery and have profound impacts on osteoclastogenesis and migration of macrophages. 
Actin remodeling for the particle phagocytosis activates the ERK pathway leading to 
inflammatory gene expression, which regulate osteoclast differentiation and migration, such as 
IL6, Cox2, MCSF and MCP1. Although we previously identified that osteogenic cells secrete 
inflammatory cytokines after phagocytosis of wear particles (66, 134), it was hard to conclude 
whether osteogenic cells have a major role in the osteolysis because there are other types of cells 
exposed to wear particles at the site of bone implant. Thus, we still needed to validate the 
involvement of osteogenic cells in inflammatory osteolysis and their impacts on other cellular 
behaviors. For these reasons, we developed an osteogenic cell-line-specific, ERK-dysfunctional 
mouse using an osterix-promoter-driven-CRE-loxp system. Since osterix, a transcription factor 
of osteoblast differentiation, is expressed in osteoprogenitors, osteoblasts, and osteocytes (32, 
135), we were able to consistently generate ERK-dysfunctional osteogenic cells by crossing 
osterix-CRE and dominant negative MEK1-loxp mice. We utilized 11-12 weeks old mice 
because osterix driven CRE mice showed lower body weight and smaller bone at 6 weeks of age. 
Similar to other studies (136), our CRE mice showed restored body weight and bone length by 
10 weeks of age. Similar bone phenotypes and osterix expression were observed from WT/WT, 
CRE/WT, WT/dn-MEK1, and CRE/dn-MEK1 groups at the time of Ti injection (Fig 1.A). Ti 
particles were implanted on the pericranium layer without an invasive incision to avoid wound 
induced-inflammation. Significantly reduced osteoclastogenesis in the Ti-treated WT/dn-MEK1 
group was observed when compared to the Ti-treated WT/WT group (Fig 1). WT/dn-MEK1 
mice also showed decreased levels of MCSF, IL6, and Cox2 expression which are considered as 





CRE/dn-MEK1 mice was confirmed via in vivo immunochemistry staining and in vitro western 
blot analysis using isolated osteogenic cells from the mouse calvaria (Fig 1.C & Fig 4.A). 
Privously, we reported that pERK pathway is a key intra cellular signaling pathway which 
regulates IL6, Cox2 gene expression in osteogenic cells (66). As we observed osteogenic cells 
induced osteolysis without help of circulating immune cells such T and B cells (137), these 
results imply that the innate immune function of osteogenic cells plays a significant role in 
inflammatory osteoclastogenesis and the pERK pathway is a key conduit that regulates the innate 
immune responses of osteogenic cells.  
 Interestingly, we observed not only decreased inflammatory osteolysis, but also 
significantly reduced infiltration of CD11b positive cells from WT/dn-MEK1 mice at the site of 
particle implantation. Based on these results, we hypothesized that osteogenic cells regulate 
migration of CD11b positive macrophages and osteoclastogenesis by secreting MCP1, IL6, 
Cox2, and MCSF. To prove our hypothesis, we further investigated in-depth, the cellular 
mechanism regarding cross-talk between osteogenic cells and macrophages through a transwell 
co-culture system. In this study, we inhibited pERK expression using a CRE-loxp system 
without interfering actin remodeling (Fig 4). Compared to WT/WT, Ti treated osteogenic cells 
from WT/dn-MEK1 showed decreased phosphorylation of CCAAT/enhancer-binding protein 
beta (pCEBP-β) which is a transcription factor for IL6, Cox2, and MCP1 gene expression. 
Decreased inflammatory gene expression from CRE/dn-MEK1 osteogenic cells resulted in 
strikingly decreased inflammatory (TNFa and IL1b) and osteoclastogenesis (TRAP, CstK, 
MMP9) from co-cultured BMMs. We also validated that osteogenic cells regulate macrophage 
cell migration through secreting MCP1 cytokines. MCP1 is known to show chemotactic activity 





MCP1 using anti-CCL2 antibodies inhibits infiltration of T cells and macrophages (140). High 
levels of MCP1 mRNA expression and chemotactic activity for BMMs were observed from Ti 
treated WT/WT osteogenic cells while ERK dysfunctional cells showed decreased MCP1 mRNA 
expression and cell migration. As Fig 1.A shows, few CD11b positive macrophages were present 
in the pericranium layer of no treatment WT group while abundant osterix positive cells existed. 
Thus, we concluded that Ti contacted osteogenic cells recruit macrophages to the site of damage 
by secreting MCP1 and help them to differentiate into osteoclastogensis through MCSF, Cox2 
and IL6 expression.  
Next, we extended our study to examine the effects of ERK inhibitor on 
osteoclastogenesis in vivo. AZD6244 is a potent, selective, and ATP-uncompetitive inhibitor of 
MAPK/ERK kinase ½ (141). It is an experimental anti-cancer drug that is currently in phase II 
(clinical) trials overseen by the U.S. Food and Drug Administration (FDA). Consistent with our 
previous in vitro study, Treatment with AZD6244 significantly decreased pERK and 
inflammatory factor expression (IL6 and Cox2) in the pericranium (Fig 4.7). The reduced 
inflammatory responses resulted in the significant decrease of osteoclastogenesis and 
macrophage accumulation on the calvaria suture line seven days post-treatment (Fig 4.8). We 
have shown that the ERK pathway is involved in inflammatory cascades in various cell lines 
including macrophages (87). Thus, our data supports that the ERK pathway could be an 










Figure 4.1. CRE/dn-MEK1 mice show decreased metal particle induced osteoclastogeneis 
and immune responses. A) Total body x-ray images of wild-type C57BL/6(WT), CRE, MEK, 
and CRE/dn-MEK1 transgenic mice. B) H&E images of the coronal calvaria bone with 2X and 
10X magnification. C) Immunohistochemical staining of pERK positive cells after Ti particle 
implantation in WT and CRE/dn-MEK1mice (40X). D) Immunostaining of TRAP positive 
osteoclasts (white arrow) in Ti treated WT and CRE/dn-MEK1 mouse calvaria. E)Quantification 







Figure 4.2. Inhibition of the ERK pathway in osteogenic cells minimizes Ti-particle-
induced bone resorption. A) Microcomputed tomography (uCT) images of untreated WT, Ti-
treated WT and Ti-treated CRE/dn-MEK1 mice calvaria (Axial view) B) Coronal suture 
morphology of selected area (yellow line). C&D) Immunohistochemisty staining of WT, WT_Ti, 







Figure 4.3. Actin remodeling for Phagocytic function of osteogenic cells is not affected by 
ERK blockage. A-B) Inhibition of ERK in osteogenic cells from CRE/dn-MEK1 mice is 
confirmed through fluorescent immunocytostaining and western blot analysis of pERK, ERK, 
GFP and GAPDH. C) After 3 hours of treatment with fluorescent beads that are smaller than a 
micron, fluorescent images of actin filaments are obtained and projected into axial, coronal and 
sagittal view by confocal microscopy to visualize the internalization of the beads. D) The 
percentage of Ti-occupied area out of the total cell surface is calculated based on images from a 
JAVA program.  E) The quantification analysis of cells associated with Ti particles is shown. 






Figure 4.4. The ERK pathway mediates inflammatory responses of osteogenic cells to metal 
particles through ERK-CEBP/beta signaling cascades. A) Relative osterix and OCN gene 
expression of primary osteogenic cells from WT, CRE/dn-MEK1, and bone marrow 
macrophages (BMM) are assessed to confirm the purity of isolated osteogenic cells from mouse 
calvaria. C) Immunoblots of osteogenic cells from WT and CRE/dn-MEK1 show the level of 
phosphorylation of ERK 1/2 and CEBP/b after stimulation with Ti particles and LPS.  D-G) 
Relative gene expressions of MCP1, MCSF, IL6 and Cox2 in CRE/dn-MEK1 cells are assessed 
to compare with WT cells. Every gene expression assay is normalized by GAPDH and n=6. Each 







Figure 4.5. Osteogenic cells orchestrate inflammatory responses in the macrophages in an 
ERK dependent manner. A-C) Inflammatory gene expression of BMMs after co-cultured with 
Ti-treated osteogenic cells for 24hours. D-F) Osteoclastogenic gene expression of BMMs after 








Figure 4.6. BMMs migration to the site of metal particle implant is accelerated by 
osteogenic cells.  A) Migration of BMMs is assessed through a modified Boyden chamber 
system. BMMs are co-cultured with Ti-treated osteogenic cells without direct contact. Migrated 
BMMs are quantified by measuring relative fluorescence. B) MCP1 expression and CD11b 
positive cell migration In vivo  are observed from Sham, Day 1_Ti, Day 3_Ti, and Day 7_Ti 







Figure 4.7 The effects of AZD treatment on inflammatory responses to Ti particles in vivo.   
Four groups were examined to investigate the effects of AZD on inflammation: Sham, 7 day Ti 
treated, 7 days AZD treated, and 7 days AZD+Ti treated groups. Immunohistochemical staining 










Figure 4.8. AZD treatment reduces osteoclastogenesis induced by Ti particles in vivo.  
To investigate the effects of AZD treatment on osteoclastogenesis, quantification of TRAP 
positive osteoclasts at the suture line was performed at 10X magnification. Representative TRAP 
positive osteoclasts were photographed from four groups: Sham, 7 day Ti treated, 7 days AZD 









Chapter 5. Summary and Future Studies 
5.1 Summary 
 The objective of this study was to identify the unknown innate immune function of 
osteogenic cells and their effects in inflammamtory osteolysis.  To achieve this end, innate 
immune celluar responses to wear particle and mechanical perturterbation were explored 
(Chpater 2). Phgocytic function and inflammatory gene expressions were detected from  Ti 
treated osteogenic cells. We developed In vivo calvaria models for Ti induced inflammatory 
osteolysis and confirmed the effects of osteogenic cells on the osteolysis (Chapter 3). Osteogenic 
cell specific ERK deficient mice were employed to discover  the ERK pathway as one of the key 
inflammatory cascades in osteogenic cells. Theraputic potential of ERK inhibitors was also 
tested. (Chapter 4). This study thus have shown that Phagocytic actin remodeling-ERK1/2-
CEBP/β axis mediated innate immune functions of osteogenic cells and is a strong therapeutic 
taget for treatment of inflammatory dieases.  
5.1.1 Super Physiological Level of Strain Exaggerates Titanium Particle Induced  
Inflammation  
The interface between bone tissue and metal implants undergoes various types of 
mechanical loading, such as strain, compression, fluid pressure, and shear stress, from daily 
activities. Such mechanical perturbations create suboptimal environments at the host bone-
implant junction, causing an accumulation of wear particles and debilitating osseous integration, 
potentially leading to implant failure. While many studies have focused on the effect of particles 
on macrophages or osteoprogenitor cells, differential and combined effects of mechanical 
perturbations and particles on such cell types have not been extensively studied. In this study, 





mechanical stimuli in the presence and absence of Ti particles with the aim of simulating various 
microenvironments of the host bone-implant junction. Macrophages and osteoprogenitor cells 
were capable of engulfing Ti particles through actin remodeling and also exhibited changes in 
mRNA levels of proinflammatory cytokines under certain conditions. In osteoprogenitor cells, 
superphysiological strain increased proinflammatory gene expression; in macrophages, such 
mechanical perturbations did not affect gene expression. We confirmed that this phenomenon in 
osteoprogenitor cells occurred via activation of the ERK1/2 signaling pathway as a result of 
damage to the cytoplasmic membrane. Furthermore, AZD6244, a clinically relevant inhibitor of 
the ERK1/2 pathway, mitigated particle-induced inflammatory gene expression in 
osteoprogenitor cells and macrophages. This study provides evidence of more inflammatory 
responses under mechanical strains in osteoprogenitor cells than macrophages. Phagocytosis of 
particles and mechanical perturbation costimulate the ERK1/2 pathway, leading to expression of 
proinflammatory genes. 
5.1.2 Osteogenic Cell Phagocytose Wear particles with Actin remodeling and Secrete 
Inflammatory Cytokines through ERK Pathway  
Wear particles at the host bone-implant interface are a major challenge for successful 
bone implant arthoplasties. Current understanding of aseptic loosening consists of macrophage-
mediated inflammatory responses and increasing osteoclastogenesis, which lead to an imbalance 
between bone formation and resorption. Despite its significant role in bone regeneration and 
implant osteointegration, the osteoprogenitor response to wear particles has been examined 
recent years. More specifically, the intracellular mechanism of osteoprogenitor mediated 
inflammation has not been fully elucidated. In this study, we examined the role of 





inflammatory cascade. Through both in vivo and in vitro experiments, we have demonstrated 
that osteoprogenitor cells are capable of initiating inflammatory responses by phagocytosing 
wear particles, which lead to subsequent accumulation of macrophages and osteoclastogenesis, 
and the ERK_CEBP/β intracellular signaling is a key inflammatory pathway that links 
phagocytosis of wear particles to inflammatory gene expression in osteoprogenitors. This study 
advances our understanding of the mechanisms of osteoprogenitor-mediated inflammation. 
 
5.1.3 Inflammatory Cytokines Induce by Osteogenic Cells Mediate Macrophage Migration 
and Osteoclastogenesis   
Discovery of the RANKL-RANK-OPG axis of osteoclastogenesis led to remarkable 
investigation of cross talk between osteogenic and osteoclast progenitor cells. As effects of the 
communication between the bone cells on bone homeostasis revealed, fundamental questions 
arise regarding communication of the bone cells to other resident cells. As inflammation has 
been a big issue for successful arthroplasties, communication between bone cells and immune 
cells has recently draw attention in the field of orthopaedics. Many studies have been performed 
on inflammatory responses of immune cells to foreign bodies, however, cross talk between bone 
cells and immune cells still is not fully understood. In this study, we aimed to identify and 
explore the innate immune responses of osteogenic cells to wear particles as well as their cross 
talk with macrophages. Previously, we identified ERK cascades as a key inflammatory pathway 
in osteogenic cells. To investigate the role of osteogenic cells in inflammatory osteolysis, we 
developed an osteogenic cell-line-specific ERK-dysfunctional mouse (CRE/dn-MERK1) using 
an osterix-promoter-driven-CRE-loxp model. In vivo Mouse Calvaria experiments showed that 
significantly reduced pERK, MCSF, IL6, Cox2, and inflammatory osteolysis in the Ti-treated 





mouse calvaria model, decreased Ti-induced inflammatory gene expression was observed from 
primary osteogenic cells from CRE/dn-MEK1 mice. Interestingly, we observed not only 
decreased inflammatory osteolysis, but also significantly reduced infiltration of CD11b positive 
cells and MCP1 expression from CRE/dn-MEK1 mice at the site of particle implantation.  
Furthermore, AZD6244 treatment, a potent inhibitor of the ERK pathway, attenuated particle 
mediated inflammatory osteolysis both in vivo. This study provides novel insights about innate 
immune function of osteogenic cells and evidence that the ERK_CEBP/β pathway may be a 
suitable therapeutic target in the treatment of inflammatory osteolysis. 
 
5.2 Future Studies 
Despite its clinical importance, the molecular mechanism behind inflammatory osteolysis 
is not fully understood. Previously, most studies focused on the role of immune cells such as 
macrophages and lymphocytes in orthopaedic field. However, there is gowning evidence 
showing that the novel innate immunity of non-immune cells may govern certain types of 
inflammatory diseases (126).  In this chapter, we propose future studies which will be followed 
from the findings of this thesis.  
5.2.1 Surface receptors for wear particles phagocytosis.  
Even though various studies have investigated cellular responses to wear particles to 
prevent inflammatory osteolysis, very little is known regarding how cells recognize wear 
particles and initiate phagocytosis. Unlike endotoxins or bacteria, wear particles are mostly inert 
and there are no cell surface receptors identified for wear particle phagocytosis (51). A few 
studies reported that opsonization by host serum enable macrophages to phagocytose 





particles are engulfed through scavenger receptor which is an opsonin independent process (62).  
The size and shape of wear particles are also important considerations in studying cell surface 
interaction. Submicron wear particles are known as culprits for severe proinflammatory cytokine 
secretion and bone resorption, while bulk or relatively lager wear particles induce less foreign 
body reaction (17, 143, 144). Elongated particles induce more inflammatory responses than 
round shape paricles (124, 144). These various responses to different types of wear particles 
suggest that either (1) there are many different phagocytic receptors for different wear particles 
or (2) innate immune functions of cells are activated in a receptor independent way. We have 
shown that osteogenic cells can sense mechanical force and engulf particles through actin 
remodeling (66, 134). Thus, the relationship between the mechanical force induced by wear 
particles and actin remodeling is an interest for future studies.  
5.2.2 Various models for inflammatory study 
Bone tissues experience many different types of mechanical loading, such as strain, 
compression, and shear stress, from daily activities (18-20). Bone cells including osteoblasts and 
osteocytes are sensitive to these various mechanical loadings and undergoe bone remodeling 
through a feedback mechanism (20). For patients with bone implants, the mechanical loading not 
only affects osseous integration between host bone and implant but also generates wear particles 
at the bearing surfaces (22-24). In this thesis, we proposed that phagocytosis of metal particles 
and super-physiological strains costimulate the ERK1/2 pathway, leading to expression of 
proinflammatory genes. Our study is limited by the absence of other mechanical stimuli, such as 
compressive, bending, and torsional forces. There are many studies that have focused on how 
bone cells respond to mechanical stresses and their effects on bone homeostasis. Proliferation 





Recently, research has been focused on the mechno-sensitivity of osteocytes (148). Although it is 
hard for osteocytes to contact wear particles directly, it will be interesting to study how the 
osteocytes will respond to altered mechanical stresses of the implant patient.  Since cells are 
exposed to various mechanical perturbations in clinical scenarios, in-depth investigations of 
cellular responses to those mechanical stimuli are needed.  
In this thesis, we utilized modified an In vivo mouse calvaria model to mimic Ti induced 
inflammatory osteolysis. Our transgenic mouse calvaria model provided valuable insight of key 
molecular pathways involved in inflammatory osteolysis. However, the mouse calvaria model is 
distinguished from an actual patient by absence of a loaded implant. Since it is hard to control 
the wear particle generation and mobility of animal model, we were not able to generate 
consistent results from the implant loaded model. Since the time required to induce osteolysis is 
shorter than 1 week, the mouse calvaria model is not a proper model to reflect the chronic nature 
of inflammatory osteolysis. Thus, the development of implant loaded mouse models will be the  
next step to mimic the clinical scenario.  
 
5.2.3 Therapeutic challenges  
Improvement of the bone implant design and surgical methodology has been considered 
as main targets for successful arthroplasites. As understanding about wear particle mediated 
inflammation is enhanced, many studies have begun to focus on biological therapeutic solutions 
for periprosthetic osteolysis. The discovery of RANK/RANKL signaling pathway for 
osteoclastogenesis has led the discovery of NFkb pathway inhibitors such as AMG-162 and 
erythromycin (EM)(149-151). However, there is a study suggesting that TNFa and IL1b 





RANKL (152). Many anti-inflammatory drugs such as Cox2 inhibitors and TNF antagonists, 
were also tested and showed optimistic results in animal models (98, 153, 154). However, since 
these drugs are systemic therapies, many side implications were reported (155, 156). Due to their 
low efficiency and non-specificity, there is no anti-inflammatory or anti-osteoclasotogenesis 
drug available for periprosthetic patients. Thus, we need to shift the clinical paradigm from 
treatment to early diagnosis and prevention. Since osteolysis around bone implants is a silent 
process, early diagnosis is the most challenging. In this thesis, we suggested that there are early 
inflammatory responses from resident cells through the ERK pathway to wear particles. Early 
detection of inflammations from resident cells using optical imaging and blocking agents to 
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